university of miami - ohio state university · web viewobstetrics & gynecology 2005;105:1381-8....

UNIVERSITY OF MIAMICurriculum Vitae

Date: May 15, 2015

I. PERSONAL

Name: Robert S. Kirsner, M.D., PhD Phone Home: (305) 669-2754 Phone Office: (305) 243-4472

Address (home): 5821 SW 132nd Terrace Pinecrest, Florida 33156-7266

Status: Full-Time

Current Rank: Chair (Interim)Professor (Tenured) of DermatologyProfessor of Epidemiology and Public HealthEndowed Harvey Blank Professor

Primary Department: Department of Dermatology and Cutaneous Surgery Citizenship: United States

Visa Type: "Not applicable"

II. HIGHER EDUCATION

1980 - 1981 SOUTHERN ILLINOIS UNIVERSITY Carbondale, Illinois

1981 - 1984 TEXAS A & M UNIVERSITY College Station, Texas Bachelor of Arts in Chemistry

1984 - 1988 UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Miami, Florida Doctor of Medicine

1

1996 - 2004 UNIVERSITY OF MIAMI SCHOOL OF MEDICINEDepartment of Epidemiology / Public HealthDoctor of Philosophy

POST DOCTORAL TRAININGa. Internship 07/88 - 06/89 UNIVERSITY OF MIAMI/JACKSON

MEMORIAL HOSPITALDepartment of Internal MedicineMiami, FloridaIntern

b. Residency 07/89 - 06/90 UNIVERSITY OF MIAMI/JACKSON

MEMORIAL HOSPITAL Department of Internal Medicine Miami, Florida Resident

07/92 - 06/94 UNIVERSITY OF MIAMI/JACKSON MEMORIAL

HOSPITAL Department of Dermatology Miami, Florida

Resident 07/94 - 06/95 UNIVERSITY OF MIAMI/JACKSON

MEMORIAL HOSPITAL Department of Dermatology Miami, Florida Chief Resident

c. Fellowship: 07/90 - 06/92 UNIVERSITY OF MIAMI/JACKSON MEMORIAL HOSPITAL

Department of Dermatology Miami, Florida Fellow in Wound Healing

BOARD CERTIFICATION AND LICENSURES

03/89 Diplomate, National Board of Medical Examiners. 03/90 Florida Medical License #ME-0058219.10/95 Diplomate, American Board of Dermatology.

2

6/05 Re-Certified, American Board of Dermatology05/97 Diplomate, American Academy of Wound Management05/04 American Society of Mohs Surgery

II. PROFESSIONAL EXPERIENCE III.Academic01/95 - 06/95 Instructor UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Department of Dermatology & Cutaneous Surgery Miami, Florida

02/95 - 09/98 Consultant DermatologistGERIATRIC CENTERCedars Medical CenterMiami, Florida

07/95 – 6/01 Assistant Professor of Clinical Dermatology UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Department of Dermatology & Cutaneous Surgery Miami, Florida

6/01 – 6/06 Associate Professor of Clinical DermatologyUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

Department of Dermatology & Cutaneous Surgery Miami, Florida

07/95 – 8/02 Associate Chief of Inpatient Services CEDARS MEDICAL CENTER Department of Dermatology Miami, Florida

07/95 - Present Attending Physician JACKSON MEMORIAL MEDICAL CENTER

Department of Dermatology Miami, Florida

08/95 - Present Attending Physician VETERANS ADMINISTRATION MEDICAL CENTER Department of Dermatology Miami, Florida

02/97 - 6/98 Co-Director - Wound C.U.R.E. Center CEDARS MEDICAL CENTER

3

Miami, Florida

06/98 – 12/07 Director - Wound C.U.R.E. CenterCEDARS MEDICAL CENTER/UNIVERSITY OF MIAMI HOSPITALMiami, Florida

07/02 – 9/04 Chief of Dermatology VETERANS ADMINISTRATION MEDICAL CENTER Department of Dermatology Miami, Florida

01/06 – Present Vice- ChairmanUNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE


6/06 – Present Professor (Tenured) of DermatologyUNIVERSITY OF MIAMI SCHOOL OF MEDICINE


12/07 - Present Director - Wound CenterUniversity of Miami HospitalMiami, Florida

12/07 – Present Chief of DermatologyMedical Executive Committee MemberUniversity of Miami HospitalMiami, Florida

01/08 – 11/14 Stiefel Laboratories Professor of Medical DermatologyEndowed Chair

07/08 – Present Professor (Tenured) of Epidemiology and Public HealthUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

Department of Epidemiology and Public Health Miami, Florida

12/14 – Present Chairman (Interim)Harvey Blank Professor Endowed ChairUNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE


4

HOSPITAL AFFILIATIONS

02/95 – 11/07 CEDARS MEDICAL CENTER Miami, Florida

03/95 - Present KINDRED/VENCOR/THC HOSPITAL Hollywood, Florida

07/95 - Present JACKSON MEMORIAL MEDICAL CENTER Miami, Florida

08/95 - Present VETERANS ADMINISTRATION MEDICAL CENTER Miami, Florida

01/96 - Present SYLVESTER COMPREHENSIVE CANCER CENTERMiami, Florida

10/05 - Present SYLVESTER COMPREHENSIVE CANCER CENTERDeerfield Beach, Florida

12/07 - Present UNIVERSITY OF MIAMI HOSPITAL Miami, Florida

IV. PUBLICATIONS BOOKS AND BOOK CHAPTERS

1) Kirsner RS, Falanga V: The technique of skin grafting. J Dermatol Surg Oncol 1993; 19: 779-783. 2) Kirsner RS, Eaglstein WH: The wound healing process. Dermatology Clinics 1993; 11: 629-640.

3) Kirsner RS, Kerdel FA: Sarcoidosis. In: Cutaneous Medicine and Surgery. Arndt KA, Leboit PE, Robinson JK, Wintroub BU.

W.B. Saunders, Philadelphia, 1995.

4) Berman B, Kirsner RS . The Miami Review for the Certifying examination of the American Board of Dermatology.

Mosby-Wolfe Publisher, London, 1996.

5) Berman B, Kirsner RS, Machler BC. The 1997 Miami Review for the Certifying examination of the American Board of Dermatology.

Mosby-Wolfe Publisher, London, 1997.

5


Mosby-Wolfe Publisher, London, 1998

7) Kirsner RS: Metrotrexate Protocol and Patient Satisfaction. American Academy of Dermatology: Quality of Care Manuel.

American Academy of Dermatology, Evanston, IL 1999

8) Kirsner RS: Venous Ulcers. Conn’s Current Therapy. W.B. Saunders Publisher, New York, 1999



10) Federman DG, Kirsner RS: The primary care physician and the dermatologist in the treatment of patients with skin disease.

Dermatology Clinics 2000;18:215-221.

11) Kerdel FA, Kirsner RS: Inpatient Dermatology. Dermatology ClinicsMosby-Wolfe Publisher, St. Louis 2000



13) Kirsner RS, Hannon W, Agarwal A, Kerdel FA: The effect of health care delivery systems on admission to and treatment at an inpatient dermatology unit.


14) Prodanovich S, Kirsner RS, Taylor JR: Treatment of patients hospitalized with psoriasis. Dermatology Clinics 2000;18:425-435.

15) Yang D, Kerdel FA, Kirsner RS: Inpatient Dermatology: The difficulties, the reality, and the future.


16) Prodanovich S, Kirsner RS, Kerdel FA: Inpatient Dermatology: A prescription for survival.




6

18) Kirsner RS, Bogensberger G: The Wound Healing Process. In: Wound Healing Alternatives in Management. 3rd Edition. McColluch JM, Kloth LC, Feedar JA.

F.A. Davis Company, Philadelphia, 2001

19) Bello YM, Falabella AF, Kirsner RS. Tissue Engineered Skin. In: Tissue Engineering and Biodegradable Equivalents: Scientific and Clinical Applications edited by Kai-Uwe Lewandroski, Donald L. Wise, Debra J. Trantolo, Joseph D. Gresser, Michael J. Yaszemski & David E. Altobelli.

Marcel Dekker Inc. New York, NY.






23) Drosou A, Kirsner RS: Keratinizing Disorders. In: Dematology- Just The Facts. Eds: Kerdel FA, Jimenez-Acosta F

McGraw-Hill, New York, 2003

24) Trent J, Kirsner RS: Skin Grafting. In: Techniques in Dermatologic Surgery. Eds: Nouri K, Leal-Khouri S.

Mosby, Edinburgh, 2003

25) Kirsner RS: Wound Healing. In: Dermatology. Eds: Bolognia JL, Jorizzo JL, Rapini RP.Mosby, New York, 2003

26) de Araju T, Kirsner RS: Atypical wounds. In Wound Care Essentials. Eds Baranoski S, Ayello EA.

Lippincott Williams & Wilkins, 2004

27) Falabella AF, Kirsner RS: Wound Healing. Eds Falabella AF, Kirsner RS: Marcel Dekker, Inc, 2005

28) Kirsner RS, Banwell PE: Adjunctive Wound Therapies. In Clinical Care of the Diabetic Foot. Eds. Armstrong DG, Lavery LA.

American Diabetes Association, 2005

29) Rouhani P, Hu S, Kirsner RS: Melanoma in Non White Populations. In Skin Cancer Ed

7

Nouri K.

30) Rouhani P, Hu S, Kirsner RS: Non Melanoma Skin Cancers in Non White Populations. In Skin Cancer. Ed Nouri K.

31) Ramirez C, Kirsner RS: NSAIDS for the Treatment of Skin Cancer. In Skin Cancer. Ed Nouri K.

32) Federman DG, Kravitz JD, Kirsner RS, Heald PW: Cutaneous Metastases. In Skin Cancer. Ed Nouri K.


34) Kirsner RS: Diabetic Foot Ulcers. In Wound and Lymphedema Management 2010: World Health Organization (WHO)

35) Kirsner RS: Atypical Ulcers. In Wound and Lymphedema Management 2010: World Health Organization (WHO)

36) Escandon J, Kirsner RS. Venous Ulcers. In Evidence Based Dermatology 2010



39) Weinstein DA, de Araju T, Kirsner RS: Atypical wounds. In Wound Care Essentials. Eds Baranoski S, Ayello EA.

Lippincott Williams & Wilkins, 2011

40) Tang L, Kirsner RS, Li, J: Extracellular matrix molecules in skin wound repair In

41) Tang J, Kirsner RS: Atypical wounds In Measurement of Wound Healing: Science and Management

Springer 2011

42) Li J, Bonilla- Martinez ZL, Kirsner RS: Wound Healing In: Dermatologic Surgery Eds Robinson J,

43) Nolan K. Braun LR. Kirsner R. (2012) Procedural Dermatology: Wound Healing. Book Chapter. McGraw-Hill.

8

44) Bonilla- Martinez Z, Kirsner RS: Venous Ulcers. Conn’s Current Therapy. W.B. Saunders Publisher, New York, 2012

45) Vivas AC, Richmond NA, Kirsner RS: Topical and Biological Therapies for Diabetic

Foot Ulcers Med Clin North Am. 2013 Sep;97(5):883-98.

46) Lamel S, Bonilla- Martinez ZL, Kirsner RS: Wound Healing In: Dermatologic Surgery Eds Robinson J, 2013

JURIED OR REFEREED JOURNAL ARTICLES

1) Weiss DS, Kirsner RS, Eaglstein WH: Electrical stimulation and wound healing.Arch Dermatol 1990; 126: 222-225.

2) Falanga V, Kirsner RS, Katz MH, Eaglstein WH, Kerdel FA: Stanozolol in the treatment of leg ulcers due to cryofibrinogenemia.

Lancet 1991; 338: 347-348.

3) Katz MH, Alvarez AF, Kirsner RS, Eaglstein WH, Falanga V: Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth.

J Am Acad Dermatol 1991; 25: 1054-1058.

4) Bieley HC, Kirsner RS, Reyes BA, Garland LD: Determination of residual tumor in incompletely excised basal cell carcinomas utilizing Mohs micrographic surgery.


5) Falanga V, Kirsner RS, Katz MH, Gould E, Eaglstein WH, McFalls S: Pericapillary fibrin cuffs in venous ulceration: Persistence with treatment and during ulcer healing.

J Dermatol Surg Oncol 1992; 18: 409-414.

6) Kirsner RS , Falanga V: Features of an autoimmune process in mid-dermal elastolysis.J Am Acad Dermatol 1992; 27: 832-834.

7) Kirsner RS, Pardes JB, Falanga V: L-tryptophan associated progressive systemic sclerosis.

Eur J Derm 1992; 2: 549-551.

8) Falanga V, Katz MH, Kirsner RS, Alvarez, AF: The effects of Endothelin-1 on human dermal fibroblast growth and synthetic activity.

J Surg Res 1992; 53: 515-519.

9) Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V: Stanozolol causes rapid pain relief and healing of cutaneous ulcers due to cryofibrinogenemia.

9


10) Kirsner RS , Pardes JB, Falanga V: Solitary fibrosing paraspinal plaque: Solitary morphea profunda?

Br J Dermatol 1993; 128: 99-101.

11) Kirsner RS, Pardes JB, Eaglstein WH, Falanga V: The clinical spectrum of lipodermatosclerosis.


12) Kirsner RS , Haiken M, Garland LD: Margin assessment of selected basal cell carcinomas utilizing laser doppler velocimetry.

Int J Dermatol 1993; 32: 390-292.

13) Kirsner RS , Goodless D, Kerdel FA, Pardes JB, Falanga V: Enlargement of hands and feet in a chronic smoker.

Arthritis Rheum 1993; 36: 569-571.

14) Kirsner RS , Falanga V, Eaglstein WH: The biology of skin grafts: Skin grafts as pharmacologic agents.

Arch Dermatol 1993; 129: 481-483.

15) Kirsner RS , Katz MH, Eaglstein WH, Falanga V: The biology of wound fluid.Wounds 1993; 5: 122-128.

16) Falanga V, Kirsner RS: Low oxygen stimulates proliferation of fibroblasts seeded as single cells.

J Cell Physiol 1993; 154: 506-510.

17) Lima-Maribona J, Kirsner RS, Kerdel FA: Leg ulcer due to sickle cell anemia.J Am Acad Dermatol 1993; 29: 802-807.

18) Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes JB, Ochoa M: Low oxygen tension increased mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts.

J Cell Physiol 1993; 157: 408-412.

19) Kirsner RS , Garland LG: Squamous cell carcinoma arising from chronic osteomyelitis treated by Mohs micrographic surgery.

J Dermatol Surg Oncol 1994; 20: 141-143.

20) Asuncion AMV, Federman DG, Kirsner RS: Swelling of the ear in a patient with ulcerative colitis.

Arthritis Rheum 1994; 37: 432-434.

10

21) Federman D, Valdivia M, Kirsner RS: Secondary syphilis presenting as the "Blue Toe Syndrome".

Arch Int Med 1994; 154: 1029-1031.

22) Falanga V, Brown H, Pardes JB, Kirsner RS: Leg ulceration due to the antiphospholipid syndrome: Successful treatment with intralesional corticosteroids and failure of prolonged Stanozolol treatment.

J Eur Acad Derm Vener 1994; 3: 174-177.

23) Resnik BA, Kirsner RS, Kerdel FA: Self-Assessment examination of the American Academy of Dermatology: Pemphigus Vegetans.


24) Kirsner RS , Eaglstein WH, Falanga V: Treatment of lipodermatosclerosis (Letter Reply).J Am Acad Dermatol 1994; 31: 133.

25) Kirsner RS, Anhalt GJ, Kerdel FA: Treatment with alpha-interferon associated with the development of Paraneoplastic Pemphigus.

Br J Derm 1995; 132: 474-478.

26) Federman DG, Hogan D, Taylor JR, Caralis PG, Kirsner RS: A comparison of diagnosis, evaluation and treatment of patients with dermatologic disorders.


27) Kirsner RS , Federman D: Treatment of psoriasis with calcipotriene (calcipotriol). Am Fam Physician 1995; 52: 237-240.

28) Kirsner RS , Mata SM, Falanga V, Kerdel FA: Split-thickness skin grafting of leg ulcers. The University of Miami Dermatology's Experience (1990-1993).

Dermatol Surg 1995; 21: 701-703.

29) Kirsner RS, Federman DG: Managed care: The dermatologist as a primary care provider. J Am Acad Dermatol 1995; 33: 535-537.

30) Kirsner RS , Kerdel FA, Falanga V, Katz MH, Eaglstein: Skin Grafts As Pharmacologic Agents: Pre-Wounding of the Donor Site. Br J Dermatol 1996;135:292-296.

31) Kirsner RS , Federman DG: Lack Of Correlation Between Internists’ Ability in Dermatology And Their Patterns Of Treating Patients With Skin Disease. Arch Dermatol 1996;132:1043-1046.

32) Kirsner RS , Badiavas E: Terapeutica Genica.Act Terap Dermatol 1996;19:37-40

11

33) Kirsner RS , Federman DG: The epidemiology of Non-Hodgkins Lymphoma. Connecticut Medicine 1996;60:579-582.

34) Kirsner RS , Spencer J, Falanga V, Garland LD, Kerdel FA: Squamous cell carcinoma arising in osteomyelitis and chronic wounds: Treatment with Mohs micrographic surgery vs. amputation.

Dermatol Surg 1996;22:1015-1018

35) Friedman P, Golomb C, Kirsner RS: Self-assessment examination for the American Academy of Dermatology. Angiosarcoma.

J Am Acad Dermatol 1997;36:147-148.

36) Kirsner RS , Freedberg IM, Kerdel FA: Inpatient Dermatology: Should we let it die or should we work toward regional centers?


37) Kirsner RS , Eaglstein WH, Kerdel FA: Split-thickness skin grafting for lower extremity ulcerations.

Dermatol Surg 1997;23:85-91.

38) Federman DG, Kirsner RS, Liang-Federman GS: Pica: Are you hungry for the facts.Connecticut Medicine 1997;61:207-209.

39) Federman DG, Kirsner RS, Braverman I: A patient with Cutaneous T Cell Lymphoma and Dermatomyositis.

Cutis 1997;59:277.

40) Kirsner RS , Federman DG: Ausencia de correlacion entre la preparacion de los internistas en dermatologica y sus patrones de tratamiento de los pacientes con enferedadas cutaneas.

Arch Dermatol Edicion Espanola 1997;8:12-16.

41) Kirsner RS , Federman DG: Cutaneous clues for systemic disease: Telltale skin signs enable early diagnosis.

Postgraduate Med 1997;101:137-150.

42) Hurwitz D, Kerdel FA, Kirsner RS: Hospitalization for skin disease improves quality of life.

Arch Dermatol 1997;133:797-798.

43) Colsky AS, Jegasothy SM, Kirsner RS, Kerdel FA: An unusual presentation of scabies infestation in a patient with Darier’s disease. The use of ivermectin as an adjunctive scabicide.

J Dermatol Treat 1997;8:137-138.

12

44) Bellman B, Berman B, Sasken H, Kirsner RS: Cutaneous disseminated Histoplasmosis in AIDS patients in South Florida.

Int J Dermatol 1997;36:599-603.

45) Kerdel FA, Flores J, Kirsner RS, Falanga V: Pulse corticosteroid therapy for cutaneous diseases: efficacy and side effects.


46) Golomb CA, Jegasothy M, Kirsner RS: Self-assessment examination for the American Academy of Dermatology. Paraneoplastic Pemphigus.


47) Muhart M, McFalls S, Kirsner R, Kerdel F, Eaglstein WH: Bioengineered skin.Lancet 1997;350:1142.

48) Federman DG, Kirsner RS: The abilities of primary care physicians in dermatology: Implications for quality of care.

Amer J Managed Care 1997;3:1487-1492

49) Kirsner RS , Federman DG: Quality of care: The patient’s perspective. Arch Dermatol 1997;133:1427-1431.

50) Federman DG, Concato J, Caralis PV, Hunkele GE, Kirsner RS: Screening for skin cancer in primary care settings.

Arch Dermatol 1997;133:1423-1425.

51) Kirsner RS , Eaglstein WH, Kerdel F: Injerto dermo-epidermico (“split thickness”) para las ulceras de las extremidades inferiores.

Act Terap Dermatol 1997:20:381-388

52) Kirsner RS , Federman DG: Video Display Terminals: The effect of Electromagnetic radiation.

South Med J 1998;91:12-16.

53) Colsky AS, Kirsner RS, Kerdel FA: Microbiological evaluation of cutaneous wounds in hospitalized dermatology patients.

Ostomy/Wound Management 1998;44:40-46.

54) Kirsner RS , Froelich CW: Soaps and Detergents: Understanding their composition and effect.

Ostomy/Wound Management 1998;44:62S-70S.

55) Colsky AS, Jegasothy SM, Leonardi C, Kirsner RS, Kerdel FA: Diagnosis and treatment of a case of cutaneous cytomegalovirus infection with a dramatic clinical presentation.

J Amer Acad Dermatol 1998;38:349-351.

13

56) Chang A, Spencer JM, Kirsner RS: Squamous cell carcinoma arising in a nonhealing wound and osteomyelitis treated with Mohs micrographic surgery: A case study.


57) Machler BC, Kirsner RS, Elgart GW: Routine histology for the diagnosis of onychomycosis: Evaluation of sensitivity and specificity.

Cutis 1998;61:217-219.

58) Kirsner RS , Falanga V, Eaglstein WH: The development of bioengineered skin. Trends in Biotechnology 1998;16:246-249.

59) Federman DG, Trent JT, Froelich CW, Demirovic J, Kirsner RS: Epidemiology of peripheral vascular disease: a predictor of systemic vascular disease.


60) Lehrer-Bell K, Kirsner RS, Tallman PG, Kerdel FA: Treatment of the cutaneous involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Silver Nitrate impregnated Soft-Sorb dressings.

Arch Dermatol 1998;134:877-879.

61) Colsky AS, Kirsner RS, Kerdel FA: Microbiologic evaluation of skin wound infections in hospitalized dermatology patients: The crisis of antibiotic resistance has come to the surface.

Arch Dermatol 1998;134:1006-1009.

62) Trent JT, Kirsner RS: Apligraf: A bi-layered living skin equivalent. Int J Clin Pract 1998;52:408-413.

63) Kirsner RS , Federman DG: The rationale for skin cancer screening and prevention. Amer J Managed Care 1998;4:1279-1284.

64) Kirsner RS : The use of Apligraf for acute wounds. J Derm 1998;25:805-811.

65) Kirsner RS , Federman DG: The ethical dilemma of population based medical decision making.

Amer J Managed Care 1998;4:1571-1576.

66) Kirsner RS , Kerdel FA, Liang-Federman G, Federman DG: Life-threatening skin infections.

Resident & Staff Physician 1998;44:15-22.

67) Bogensberger G, Elgart GW, Froelich CW, Kirsner RS: Lipodermatosclerosis. Wounds 1999;11 Supplement A:2A-6A.

14

68) Federman DG, Froelich CW, Kirsner RS: Topical therapy for psoriasis. Amer Fam Physician 1999;59:957-964.

69) Kirsner RS , Kerdel FA, Falanga V, Trent JT, Eaglstein WH: Dermatology education: The role of mandated research.

J Invest Dermatol 1999;112:400-401.

70) Federman DG, Kirsner RS: Leukocytoclastic vasculitis, Hepatitis B, and the risk of endoscopy.

Cutis 1999;63:86-87.

71) Federman DG, Concato J, Kirsner RS: Comparison of dermatologic diagnoses by primary care practitioners and dermatologists: A review of the literature.

Arch Fam Med 1999;8:170-172.

72) Kirsner RS , Yang DG, Kerdel FA: The changing status of inpatient dermatology at American academic dermatology programs.


73) Valencia IC, Chang A, Kirsner RS, Kerdel FA: Eosinophilic fasciitis responsive to treatment with pulsed steroids and cyclosporine.

Int J Dermatol 1999;38:369-372.

74) Rendon-Pellerano MI, Jerome L, Eaglstein WH, Kirsner RS, Hanft K, Pardo RJ: Laser resurfacing: Usual and unusual complications.


75) Baumann LS, Kerdel FA, Agrawal A, Kirsner RS: A south Florida survey on the relationship between Academic Medical Centers and community physicians.

South Med J 1999;92:673-676.

76) Muhart M, McFalls S, Kirsner RS, Elgart G, Kerdel F, Sabolinski ML, Hardin- Young J, Eaglstein WH: Behavior of Tissue-Engineered Skin: A comparison of a living skin equivalent (LSE), autograft, and an occlusive dressing on human donor sites.

Arch Dermatol 1999;135:913-918.

77) Kirsner RS , Yang D, Kerdel FA: Dermatologic disease accounts for a large number of hospital admissions annually.


78) Kirsner RS , Muhkerjee S, Federman DG: Skin cancer screening in primary care: Prevalence and barriers.


15

79) Weiss E, Golomb C, Colsky A, Kirsner RS: Leukonychia totalis. J Clin Dermatol 1999;2:14.

80) Weiss E, Brahmatewari J, Kirsner RS, Kerdel FA: Calciphylaxis in a patient with end- stage renal disease.

J Clin Dermatol 1999;2:17-18.

81) Kirsner RS , Federman DG: The changing face of dermatology: More than a cosmetic one.

Dermatopath Pract Concept 1999;5:371-373.

82) Kirsner R , Falanga V, Fivenson D, Thibodeaux K, Cavorsi J, de la Pava D, Brem H, Golomb CA: Clinical experience with a human skin equivalent for the treatment of venous leg ulcers: Process and outcomes.

Wounds 1999;11:137-144.

83) Federman DG, Kirsner RS: Acne Vulgaris: Pathogenesis and therapeutic approach. Am J Managed Care 2000;6:78-89.

84) Federman DG, Kirsner RS: Fever and a rash in a sixty-one year old man. Postgraduate Med 2000;76:237-244.

85) Sanchez J, Kirsner R, Cohen J, Kerdel FA: Treatment of Cutaneous T Cell Lymphoma with the combination of Extracorporeal Photochemotherapy and conventional Psoralen- Ultraviolet light A irradiation.


86) Sandler A, Silos S, Lowell B, Kirsner RS: Pemphigus vulgaris in a patient infected with HIV.

AIDS, Patient Care, and STDs 2000;14: 295-296.

87) Vensel E, Hilley T, Trent JT, Taylor JR, Kirsner RS, Kerdel FA, Taylor J, Schwartzberg J: Sustained improvement of quality of life after hospitalization for psoriasis.

J Amer Acad Derm 2000;43: 858-860.

88) Federman DG, Kirsner RS: Fatal bladder cancer and dermatomyositis.South Med J 2000;93: 492-493.

89) Schartzberg J, Kirsner RS: Stasis in venous ulcers: A misnomer that should be abandoned.

Dermatol Surg 2000;26: 683-684.

90) Litvak D, Kirsner RS, Pakdaman NN, Federman DG: Pyoderma gangrenosum and myelodysplastic syndrome.

S Med J 2000;93:923-925.

16

91) Brem H, Kirsner RS: Use of Graftskin (Apligraf) in the Treatment of Pressure Ulcers and Acute Wounds.

Wounds 2000;12:72A-77A

92) Bogensberger G, Eaglstein WH, Kirsner RS. Chronic leg ulcers in a patient with combined arterial and venous disease successfully treated with a human skin equivalent: A case report.

Wounds 2000;12:118-121.

93) Federman DG, Kirsner RS. Fever and a rash in a 61 year old man.Postgrad Med J 2000;76: 237, 243-4.

94) Greenberg JE, Lynn M, Kirsner RS, Hanly AJ. Clinical Practice. Mucocutaneous pigmentation due to zinc deposition.

Lancet 2000; 25 (356) (9244):1817.

95) Flores F, Eaglstein WH, Kirsner RS: Hydroxyurea-induced leg ulcer treated with Apligraf.

Ann Int Med 2000:132: 417-418.

96) Federman DG, Reid MC, Feldman SR, Greenhoe J, Kirsner RS: The primary careprovider and the care of skin disease: The patients perspective.

Arch Derm 2001;137:25-29.

97) Valencia I, Falabella A, Kirsner RS, Eaglstein WH: Chronic Venous Insufficiency and Venous ulceration.


98) Trent JT, Kirsner RS: Vasculitis: A Précis.Advances in Skin and Wound Care 2001;14:64-70.

99) Federman DG, Kirsner RS: An update on hypercoagulable disorders. Arch Int Med 2001;161:1-51-1056.

100) Kirsner RS , Federman DG: Atypical Wounds.Care Management 2001;7:2-3.

101) Kirsner RS, Orsted H, Wright JB: Matrix metalloproteinases in normal and impaired wound healing: A potential role for nanocrystalline silver.

Wounds 2001;13(Supple 3):S4-S13.

102) Kirsner RS , Federman DG: Interpretation of Cutaneous Biopsy Specimens: Choice of Pathologist by Primary Care Practitioners

South Med J 2001;94:461-463.

17

103) deAraujo TS, Kirsner RS: Vasculitis.Wounds 2001;13:97-112.

104) Trent JT, Kirsner RS: Diagnosing Pyoderma Gangrenosum Advances In Skin & Wound Care 2001;14:151-153.

105) Trent JT, Federman DG, Kirsner RS: Common Viral and Fungal Infections of the SkinOstomy/Wound Management 2001;47(6):28-34.

106) Trent JT, Federman DG, Kirsner RS: Common Bacterial Infections of the SkinOstomy/Wound Management 2001;47(8):30-34.

107) Trent JT, Kirsner RS: Calciphylaxis: Diagnosis and TreatmentAdvances In Skin & Wound Care 2001;14:309-312.

108) Brooke A. Lowell BA, Froelich CW, Federman DG, Kirsner RS: Dermatology in primary care: Prevalence and patient disposition.


109) Bello YM, Falabella AF, DeCarbalho H, Nayyar G, Kirsner RS: Infection and Wound Healing.

Wounds 2001;13:127-131.

110) Long RE, Falabella AF, Valencia I, Eaglstein WH, Kirsner RS: Treatment of refractory, atypical lower extremity ulcers with tissue engineered skin (Apligraf).

Arch Derm 2001;137:1660-1.

111) Federman DG, Moriarty JP, Kravetz JD, Kirsner RS: Thrombosis: New culprits in an old disorder.

Panminerva 2002;44:107-113.

112) Federman DG, Kirsner RS: Timing of hypercoagulable screens. Arch Intern Med 2002;162:613-4.

113) Kirsner RS , Fastenau J, Falabella AF, Long R, Valencia I, Eaglstein WH: Clinical and economic outcomes with graftskin for hard-to-heal venous leg ulcers: A single-center experience.

Derm Surg 2002;28:81-82.

18

114) Federman DH, Kravetz JD, Kirsner RS: Skin cancer screening by dermatologists: Prevalence and barriers

J Am Acad Dermatol 2002;46:710-4

115) Bello Y, Falabella AF, Kirsner RS, Elgart GE, Kerdel FA: Hypertensive UlcersWounds 2002;14:131-135.

116) Valencia IC, Falabella A, Kirsner RS, Eaglstein WH: Venous Leg UlcerationPhebology Digest 2002;15:6-11.

117) Trent JT, Kirsner RS: Diagnosing necrotizing fasciitis.Advances In Skin and Wound Care 2002;15:135-138.

118) Federman DG, Kirsner RS: The patient with skin disease. An approach for non-dermatologists.

Ostomy Wound Management 2002;48:22-28.

119) Sullivan TP, Kirsner RS: Surgical Pearl: Punch technique to improve granulation over exposed tendons in chronic wounds. J Am Acad Dermatol. 2002;47:439-40.

120) Harrison-Balestra C, Eaglstein WH, Falabella AF, Kirsner RS: Recombinant human platelet-derived growth factor for refractory nondiabetic ulcers: a retrospective series. Dermatol Surg. 2002;28:755-60.

121) Zacur H, Kirsner RS: Debridement: Rationale and Therapeutic Options Wounds 2002;14(7 Supple E):2E-7E.

19

122) Sullivan TP, Elgart GW, Kirsner RS: Pemphigus and Smoking.Int J Derm 2002;41:528-530.

123) Trent JT, Kirsner RS: Necrotizing Fasciitis.Wounds 2002;14:284-292.

124) Greenberg JE, Lynn M, Kirsner RS, Elgart GW, Hanly AJ: Mucocutaneous pigmented macule as a result of zinc deposition

Journal of Cutaneous Pathology 2002;29:613-615.

125) Martin LK, Kirsner RS: Use of a meshed bilayered cellular matrix to treat a venous ulcer.

Adv Skin Wound Care 2002;15:260-264.

126) Banta MN, Kirsner RS: Modulating diseased skin with tissue engineering: actinic purpura treated with apligraf.


127) Li J, Zhang YP, Kirsner RS: Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix.

Microscopy Research and Technique 2003;60:107-114.

128) Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent T, Margolis DJ, Saurat JH, French LE, for the TEN-IVIG Study Group: Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins: Multicenter Retrospective Analysis of 48 Consecutive Cases

Arch Dermatol. 2003;139:26-32

129) Trent JT, Kirsner RS, Romanelli R, Kerdel FA: Analysis of Intravenous Immunoglobulin for the Treatment of Toxic Epidermal Necrolysis Using SCORTEN: The University of Miami Experience. Arch Dermatol. 2003;139:39-43.

130) Geren SM, Kerdel FA, Falabella AF, Kirsner RS: Infliximab: A treatment option for ulcerative pyoderma gangrenosum

Wounds 2003;15:49-53.

20

131) Trent JT, Kirsner RS: Wounds and MalignancyAdv Skin Wound Care 2003;16:31-34.

132) De Araujo T, Valencia I, Federman DG, Kirsner RS : Managing the patient with venous ulcers.

Ann Intern Med 2003;138:326-34.

133) Jacob SE, Lodha R, Cohen JJ, Romanelli P, Kirsner RS: Paraneoplastic eosinophilic fasciitis: a case report.

Rheumatol Int 2003;23:262-264.

134) Kirsner RS : Infection and Intervention.Wounds 2003;15:127-128.

135) Drosou A, Falabella AF, Kirsner RS: Antiseptics on Wounds: An Area of Controversy.Wounds 2003;15:149-166.

136) Kirsner RS : Wound Bed Preparation. Ostomy Wound Manage 2003 Feb;Suppl:2-3.

137) Martin LK, Kirsner RS: Ulcers caused by bullous morphea treated with tissue-engineered skin.

Int J Dermatol 2003;42:402-4.

138) Trent JT, Kirsner RS: Identifying and treating mycotic skin infections.Adv Skin Wound Care. 2003;16:122-9.

139) Banta MN, Eaglstein WH, Kirsner RS: Healing of refractory sinus tracts by dermal matrix injection with cymetra.

Dermatol Surg. 2003;29:863-6.

140) Ayyalaraju RS, Finlay AY, Dykes PJ, Trent JT, Kirsner RS, Kerdel FA: Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: A comparative study.

J Am Acad Dermatol. 2003;49:249-54.

141) Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS: Infliximab for Hidradenitis Suppurativa.

Br J Dermatol 2003;149:1046-1049.

142) Trent JT, Kirsner RS: Herpesvirus infections and herpetic wounds. Adv Skin Wound Care. 2003;16:236-243.

143) Thomas- Hess C, Kirsner RS : Orchestrating Wound Healing: Assessing and preparing the Wound Bed.

21

Adv Skin Wound Care. 2003;16:246-259.

144) Federman DG, Kirsner RS, Moriarty JP, Concato J: The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49:86-864.

145) Federman DG, Kravetz JD, Kirsner RS: An Interesting Side Effect of Home Oxygen Therapy.

Ostomy Wound Manage. 2003;49:26-27

146) Trent JT, Kirsner RS: Epidermolysis bullosa: identification and treatment.Adv Skin Wound Care. 2003;16:284-90.

147) Rongioletti F, Borenstein M, Kirsner R, Kerdel F: Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.

J Dermatolog Treat. 2003;14:222-5.

148) Hess CT, Kirsner RS: Uncover the latest techniques in wound bed preparation.Nurs Manage. 2003;34:54-6.

149) Trent JT, Federman D, Kirsner RS: Skin and wound biopsy: when, why, and how.Adv Skin Wound Care. 2003; 16:372-5.

150) Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA: Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses.

J Cutan Med Surg. 2003;7:382-6.

151) Trent JT, Kirsner RS: Cutaneous Manifestations of Diabetic Disease. ECPN. 2003; 30-35.

152) Federman DG, Kravetz JD, Kirsner RS: Necrotizing fasciitis and cardiac catheterization.Cutis. 2004;73:49-52.

153) Hu S, Ma F, Collado-Mesa F, Kirsner RS: Ultraviolet radiation and incidence of non- Hodgkin's lymphoma among Hispanics in the United States.

Cancer Epidemiology, Biomarkers and Prevention. 2004;13:59-64

154) Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS: Vogt-Koyanagi-Harada syndrome and ulcerative colitis.

South Med J. 2004;97:169-71.

155) Federman DG, Bravata DM, Kirsner RS: Peripheral arterial disease: a systemic disease extending beyond the affected extremity.

Geriatrics 2004; 59: 26-36.

22

156) Federman DG, Kravetz JD, Tobin DG, Ma F, Kirsner RS: Full body skin examinations: The patient’s perspective.

Arch Dermatol 2004;140:530-534.

157) Federman DG, McNiff JM, Kirsner RS: Pancreatic panniculitis.Wounds 2004;16:140-146.

158) Trent JT, Kirsner RS: Cutaneous Manifestations of HIV: A Primer.Adv Skin Wound Care. 2004;17:116-127.

159) Trent JT, Kirsner RS: Cutaneous Manifestations of HIV: A Primer.Adv Skin Wound Care. 2004;17:127-9.

160) Ramirez CC, Kirsner RS: A refractory case of erythromelalgia involving the ears.Amer J Otolaryngology- Head and Neck Medicine 2004;25:251-254.

161) Brem H, Kirsner RS, Falanga V: Protocol for the successful treatment of venous ulcers.Am J Surg. 2004;188(1A):1-8.

162) Boulton AJM, Kirsner RS, Vileikyte L: Neuropathic Diabetic Foot Ulcers.New Engl J Med 2004;351:48-55.

163) Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS: Poor prognosis of arthritis associated pyoderma gangrenosum.

Arch Derm 2004;140:861-864.

164) Trent JT, Kirsner RS, Romanelli P, Kerdel FA: Use of SCORTEN accurately predict mortality in patients with Toxic Epidermal Necrolysis in the United States,

Arch Derm 2004;140:890-892.

165) Hu S, Ma F, Collado-Mesa F, Kirsner RS: Ultraviolet Radiation, Latitude and Melanoma in US Hispanics and Blacks.

Arch Derm 2004;140:819-824.

166) Armstrong DG, Attinger CE, Boulton AJ, Frykberg RG, Kirsner RS, Lavery LA, Mills JL: Guidelines regarding negative wound therapy (NPWT) in the diabetic foot.

Ostomy Wound Manage. 2004;50:3S-27S.

167) Valencia IC, Kirsner RS, Kerdel FA: Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period.


23

168) Charles CA, Kato T, Tzakis AG, Miller BN, Kirsner RS: Use of A Living Dermal Equivalent for A Refractory abdominal Defect after pediatric multi-visceral transplantation.

Derm Surg 2004;30:1236-40.

169) Green AR, Elgart GW, MA, F, Federman DG, Kirsner RS: Documenting Dermatology Practice: Ratio of cutaneous tumors biopsied which are malignant.

Derm Surg 2004;30:1208-9.

170) Federman DG, Kirsner RS: Inglorius "Old Glory".Connecticut Medicine 2004;68:653.

171) Poochareon V, Federman DG, Kirsner RS: Primary Prevention Efforts for MelanomaJ Drugs Dermatol 2004:3:506-519.

172) Trent JT, Kirsner RS: Leg Ulcers in Sickle Cell Disease. Adv Skin Wound Care. 2004;17:410-416

173) Martin L, Romanelli R, Ahn Y, Kirsner RS : Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder

Int J Dermatol 2004;43:922-924.

174) Hu S, Parker D, Thomas AG , Kirsner RS: Advanced Presentation of Melanoma in African American: The Miami Dade County Experience.


175) Levy D, Banta MR, Charles CA, Eaglstein WH, Kirsner RS: Cymetra: A Treatment Option for Refractory Ulcers

Wounds 2004;16:359-363.

176) Trent JT, Kirsner RS: Leg Ulcers Secondary to Prolidase Deficiency. Adv Skin Wound Care. 2004;17:468-472

177) Federman DG, Brescia G, Horne M, Kirsner RS. Cutaneous signs of malignancy.Postgraduate Medicine 2004; 115 (1). Online at http://www.postgradmed.com

178) Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS: Methotrexate Reduces Incidence of Vascular Diseases in Veterans with Psoriasis or Rheumatoid Arthritis

J Am Acad Dermatol. 2005:52:262-7

179) Ramirez CC, Federman DG, Kirsner RS: Skin Cancer as an Occupational Disease.

24

http://www.postgradmed.com/

Int J Dermatol. 2005: 44:95-100.

180) Hu S, Federman DG, Ma F, Kirsner RS: Skin Cancer and non-Hodgkin’s Lymphoma: Examining the link .

Derm Surg 2005;31:76-82

181) Federman DG, Ranani DC, Kirsner RS, Bravata DM: Lipid-Lowering Therapy in Patients With Peripheral Arterial Disease: Are Guidelines Being Met?

Mayo Clin Proc 2005;80:494-498

182) Schartzberg JB, Elgart GW, Romanelli P, Ma F, Federman DG, Kirsner RS: Accuracy and Predictors of Basal Cell Carcinoma Diagnosis

Derm Surg 2005;31:534-537.

183) Drosou A, Kirsner RS, Kato T, Mittal N, Al-Niami A, Miller B, Tzakis AG: Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation

J Amer Acad Derm 2005;52:854-8.

184) Paller AS, Lebwohl M, Fleischer AB, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ: Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies J Amer Acad Derm 2005;52:810-822.

185) Ramirez CC, Federman DG, Ma F, Kirsner RS: Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High Risk Patients.

Derm Surg 2005;31:748-752.

186) Kirsner RS , Ma F, Fleming L, Trapido E, Duncan R, Federman DG, Wilkinson JD: The Effect of Medicare Health Care Systems on Women With Breast and Cervical Cancer.

Obstetrics & Gynecology 2005;105:1381-8.

187) Kirsner RS , Wilkinson JD, Ma F, Fleming L, Federman DG, Wilkinson JD: The Association of Medicare Health Care Delivery Systems On Stage At Diagnosis And Survival For Patients With Melanoma.

Archives of Dermatology 2005:141:753-757.

188) Kirsner RS , Ramirez CC, Federman DG, Ma F: Lipid lowering agents and risk of melanoma.

Int J Cancer 2005;117:333

25

189) Trent JT, Kirsner RS: Ulcerations in Primary Hyperoxaluria.Adv Skin Wound Care 2005;18:244-247.

190) De Araujo TS, Hexsel CL, Kirsner RS: Treatment of Venous UlcersCurr Treat Options Cardiovasc Med. 2005;7:131-138.

191) Levy D, Banta MR, Kirsner RS: Refractory pyoderma gangrenosum peristomal ulcer and sinus tract treated with micronized cadaveric dermis.

J Am Acad Dermatol. 2005;52:1104.

192) Trent JT, Falabella AF, Eaglstein WH, Kirsner RS: Venous ulcers: Pathophysiology and treatment options.

Ostomy Wound Manage. 2005;51:38-56.

193) Jorgensen B, Price P, Andersen KE, Gottrup F, Bech-Thomson N, Scanlon E, Kirsner R, et al: The Silver–releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venuos leg ulcer: a randomised controlled trial.

Int Wound J 2005;2:64-73.

194) Federman DG, Brescia GR, Moriarty JP, Haskell SG, Krishnamurthy R, Kirsner RS: Update in thrombosis: answers to perplexing questions.

Cleve Clin J Med. 2005 ;72:907-15.

195) Federman DG, Enis DR, Kravetz JD, Sethi A, Kirsner RS: Toxic Epidermal Necrolysis: Report of a Fatal Case of Recurrent Disease and Literature Review.

Wounds 2005;17:296-303.

196) Kirsner RS , Parker DP, Braithwaite N, Thomas A, Tejada F, Trapido EJ: Sun protection policies in Miami-Dade County public schools: opportunities for skin cancer prevention.

Pediatric Dermatology 2005;22:513-519.

197) Kirsner RS : New approaches to a timeless dilemma.Ostomy Wound Management 2005;51(11ASuppl):2-3.

198) Federman DG, Kravetz JD, Haskell SG, Ma F, Kirsner RS: Full Body Skin Examinations and The Female Veteran: Prevalence and Perspective

Archives of Dermatology 2006;142:312-316.

199) Hu S, Soza-Vento R, Parker DF, Kirsner RS: Comparison of Stage at Diagnosis for Melanoma Among Hispanics, Blacks and Whites in Miami-Dade County

Arch Dermatol. 2006;142:704-8.

26

200) Kirsner RS : Skin care: from skin health to ulcer prevention.Ostomy Wound Management 2006;52:23-24.

201) Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O’Connell SM, Steinberg J, Falanga V: Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.

Wound Repair Regen. 2006;14:102-9.

202) Kirsner RS , Ma F, Fleming L, Federman DG, Trapido E, Duncan R, Wilkinson JD: The Effect of Medicare Health Care Delivery Systems On Survival For Patients With Breast and Colorectal Cancer.

Cancer Epidemiology, Biomarkers and Prevention 2006;15:769-773.

203) Banta MR, Ma F, Bravata D, Kirsner RS, Federman DG: Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease.

J Gen Int Med 2006;21:711-714.

204) Hu S, Kirsner RS, Falanga V, Philips T, Eaglstein WH: Evaluation of Apligraf Persistence in Donor Site Wounds: A Pilot Study.

Wound Repair and Regeneration 2006;14:427-33.

205) Federman DG, Kravetz JD, Bravata DM, Kirsner RS: Peripheral arterial disease. A marker of morbidity and mortality. Postgrad Med. 2006;119:21-7.

206) Davis SC, Martinez L, Kirsner R: The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep. 2006;6:439-45.

207) Sackheim K, De Araujo TS, Kirsner RS: Compression modalities and dressings: their use in venous ulcers. Dermatol Ther. 2006;19:338-47

208) Lyons TA, Miller MS, Serena T, Shehan P, Lavery L, Kirsner RS, Armstrong DG, Reese A, Yankee EW, Veves A: Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg. 2007;193:49-54.

209) Kirsner RS : A wound healing perspective. Clin Dermatol. 2007;25:1-2.

210) Li J, Chen J, Kirsner RS: Pathophysiology of acute wound healing. Clin Dermatol. 2007;25:9-18.

27

211) Shelling M, Prodanovich S, Kirsner RS: Cardiovascular risk factors and myocardial infarction in patients with psoriasis.

Exp Rev Derm 2007;2:19-23.

212) Trent JT, Ma F, Kerdel F, Fien S, French L, Romanelli P, Kirsner RS: Dose of intravenous immunoglobulin and patient survival in SJS and toxic epidermal necrolysis

Exp Rev Derm 2007;2:299-303.

213) Zaulyanov-Scanlan L, Kirsner RS: A review of a bi-layered living cell treatment (Apligraf®) in the treatment of venous leg ulcers and diabetic foot ulcers.

Clin Interv Aging. 2007;2:93-98.

214) Barron G, Jacob SE, Kirsner RS: Dermatologic Complications of Chronic Venous Disease: Medical management and Beyond.

Annals in Vasc Surg. 2007;21:652-662.

215) Leon A, Charles CA, Banta MR, Kirsner RS: Etanercept for the Treatment of Refractory of Pyoderma Gangrenosum: A Brief Series.

Int J Dermatol. 2007;46:1095-9.

216) Rodriguez GL, Ma F, Federman DG, Rouhania P, Chimento S, Multach M, Kirsner RS: Predictors of Skin Cancer Screening Practice and Attitudes in Primary Care.

J Amer Acad Dermatol. 2007;57(5):775-81.

217) Patel AR, Romanelli P, Roberts B, Kirsner RS: Treatment of Herpes Simplex Virus Infection (Cold Sores): Rationale for Occlusion.

Adv in Skin and Wound. 2007;20:408-412.

218) Ma F, Collado-Mesa F, Hu S, Kirsner RS: Skin cancer awareness and sun-protection behaviors in white Hispanic and white non-Hispanic high school students in Miami, Florida, U.S.

Arch Derm. 2007;143:983-988.

219) Hess CT, Kirsner RS: Silver and its use in managing wound bioburden. International Review of Patient Care. In Press.

220) Pieper B, Kirsner RS, Templin TN, Birk TJ: Injection Drug Use: An Understudied Cause of Venous Disease

Arch Derm. 2007 143:1305-9.

221) Pieper, B., Templin, TN, Birk, TJ, Kirsner, RS. Effects of injection-drug injury on ankle mobility and chronic venous disorders.

Journal of Nursing Scholarship, 2007;39:312-318.

28

222) Pieper, B, Kirsner, RS, Templin TN, Birk, TJ. (2008). Intravenoser drogenkonsum: Assoziation mit chronisch-venosen erkrankungen.

Vasomed, 2008; G7825: 32.

223) Pieper B, Templin TN, Birk TJ; Kirsner RS: Reliability and clinical validity of a technique to assess lifetime illicit injection drug use.

Ostomy Wound Manage. 2008 ;54:16-34

224) Breneman D, Fleischer AB, Abramovitis W, Ziechner J, Gold MH, Kirsner RS, Shull TF, Crowe AW, Jaracz E, Hanifin J: Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.


225) LeBlanc WG, Vidal L, Kirsner RS, Lee DJ, Caban-Martinez AJ, McCollister KE, Arheart KL, Chung-Bridges K, Christ S, Clark J, Lewis J, Davila EP, Rouhani P, Fleming LE: Reported skin cancer screening of US adult workers


226) Pieper B, Templin TN, Birk TJ, Kirsner RS: Chronic Venous Disorders and Injection Drug Use: Impact on Balance, Gait, and Walk Speed

JWOCN 2008;35:301-10.

227) Schwartzfarb ES, Weir D, Conlan WA, Romanelli P, Kirsner RS: Pyoderma gangrenosum in a patient with Bruton’s X-linked agammaglobulinemia treated with high dose immunoglobulin

J Clinical Aesthetic Dermatology 2008;1;

228) Herschthal J, Kirsner RS: Current Management of Venous Ulcers: An Evidence-Based Review.

Surg Tech Int 2008;17:77-83.

229) Rouhani P, Hu S, Kirsner RS: Melanoma in Hispanic and Black AmericansCancer Control. 2008;15:248-53.

230) Bonilla-Martinez ZL, Kirsner RS: Ulcers Caused by Breast Surgery and Abdominoplasty.Cosmetic Dermatology 2008

231) Federman DG, Kravetz JD, Haskell SG, Ma F, Kirsner RS: Patient Gender Affects Skin Cancer Screening Practices and Attitudes among Veterans

Southern Medical Journal 2008 ;101:513-8.

232) Prodanovich S, Shelling ML, Federman DG, Kirsner RS: Cytokine Milieu in Psoriasis and Cardiovascular Disease May Explain the Epidemiologic Findings Relating These Two Diseases.

29

Arch Dermatol. 2008;144:1518-9.

233) Shelling ML, Federman DG, Prodanovich S, Kirsner RS: Psoriasis and Vascular Disease: An Unsolved Mystery

Am J Med. 2008;121:360-5

234) Patel A, Romanelli P, Roberts B, Kirsner RS: Herpes Simplex Virus: A histopathological study of the depth of herpetic wounds

Int J Derm. 2009;48:36-40

235) Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS: Psoriasis: an opportunity to identify cardiovascular risk

Br J Derm 2009;160:1-7.

236) Charles CA, Tomic-Canic M, Vincek V, Nassiri M, Stojadinovic O, Eaglstein WH, Kirsner RS: A Gene Signature of Non-Healing Venous Ulcers: Potential Diagnostic Markers.

J Amer Acad Derm. 2008:5:758-771

237) Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

J Natl Cancer Inst. 2008 ;100:1223-32.

238) Pieper B, Templin TN, Birk TJ, Kirsner RS. The standing heel-rise test: relation to chronic venous disorders and balance, gait, and walk time in injection drug users.

Ostomy Wound Manage. 2008;54:18-30

239) Romanelli P, Schlam E, Green JB, Trent JT, Ricotti C, Elgart GW, Kirsner RS, Kerdel FA. Immunohistochemical evaluation of toxic epidermal necrolysis treated with human intravenous immunoglobulin.

G Ital Dermatol Venereol. 2008;143:229-33.

240) Fried L, Kirsner RS, Bhandarkar S, Arbiser JL. Efficacy of rapamycin in scleroderma: a case study.

Lymphat Res Biol. 2008;6:217-9

241) Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL; US Tacrolimus Ointment Study Group. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.

Pediatrics. 2008;122:e1210-8.

30

242) Weinstock MA, Bingham SF, Lew RA, Hall R, Eilers D, Kirsner R, Naylor M, Kalivas J, Cole G, Marcolivio K, Collins J, Digiovanna JJ, Vertrees JE; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group. Topical tretinoin therapy and all-cause mortality.


243) Federman DG, Carbone VG, Kravetz JD, Kancir S, Kirsner RS, Bravata DM. Are screening guidelines for abdominal aortic aneurysms being implemented within a large VA primary health care system?

Postgrad Med. 2009;121:132-5

244) Shiman MI, Pieper B, Templin TN, Birk TJ, Patel AR, Kirsner RS. Venous ulcers: A reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function.


245) Charles CA, Ricotti CA, Davis S, Mertz P, Kirsner RS: In vitro evaluation of biofilm development on tissue engineered skin.

Derm Surg 2009;35:1334-41

246) Newland MR, Patel AR, Prieto L, Boulton AJM, Pacheco M, Kirsner RS: Neuropathy and Gait Disturbances in Patients with Chronic Venous Ulcers: A Pilot Study

Arch Derm 2009;145:485-6.

247) Federman DG, Shelling ML, Prodanovich S, Gunderson CG, Kirsner RS: Cardiovascular health for patients with psoriasis: a précis for front-line clinicians


248) Pieper, B, Kirsner, RS, Templin TN, Birk TJ: Peripheral Arterial Disease Among Substance Abusers in Drug Treatment.

Advances in Skin and Wound Care. 2009;22:265-72.

249) Charles CA, Romanelli P, Newland MR, Kirsner RS Tumor Necrosis Factor-alpha in Non-Healing Venous Leg Ulcers


250) Sarah A. Stechschulte SA, Kirsner RS, Federman DG: Vitamin D: Bone and Beyond: Rationale and Recommendations for Supplementation

Amer J Med 2009;122:793-802.

251) Joshi SS, Romanelli P, Kirsner RS: Sarcoidosis mimicking a venous ulcer: A case report.Ostomy Wound Management 2009;55:46-8.

31

252) Prodanovich S, Kirsner RS, Kravetz J, Ma F, Martinez L, Federman DG: Association of Psoriasis with Coronary Artery, Cerebrovascular, Peripheral Vascular Diseases and Mortality

Arch Dermatol. 2009 ;145:700-3.

253) Federman DG, Concato J, Kirsner RS: Screening for Skin Cancer: absence of evidence?Arch Derm 145:926-7

254) Kirsner RS , Heffernan MP, Antaya R: The Safety and Efficacy of Tacrolimus Ointment Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids: A Subset Analysis of 3 Multicenter, Randomized Blinded, Therapeutic Trials

Acta Derm Venereol. 2010;90:58-64

255) Pieper, B, Templin TN, Kirsner RS, Birk TJ: Impact of Injection Drug Use on Distribution and Severity of Chronic Venous Disorders.

Wound Repair Regen. 2009;17:485-91

256) Miteva M, Galimberti ML, Ricotti C, Breza T, Kirsner R, Romanelli P: D2-40 highlights lymphatic vessel proliferation of angiolymphoid hyperplasia with eosinophilia.

J Cutan Pathol. 2009 Jul 7. [Epub ahead of print]

257) Federman DG, Shelling ML, Prodanovich S, Gunderson CG, Kirsner RS: Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.

Ostomy Wound Manage. 2009:55:38-47.

258) Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF VATTC Trial Group; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group.: Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Cancer. 2009;115:2523-30.

259) Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JI, Kirsner RS, Maize JC, Sullivan S, Laskas J, Hanke CW: Patient safety: Part I. Patient safety and the dermatologist


260) Weinstock MA, Lee KC, Chren MM, Marcolivio K, VATTC Trial Group Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial

J Amer Acad Dermatol 2009;61:207-215

32

261) Geng A, Weinstock MA, Hall R, Eilers D, Naylor M, Kalivas J; VATTC Trial Group.Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin. Chemoprevention Trial.

Br J Dermatol. 2009;161:918-24.

262) Rouhani P, Parmet Y, Bessell AG, Peay T, Weiss A, Kirsner RS: Knowledge, attitudes, and behaviors of elementary school students regarding sun exposure and skin cancer

Pediatr Dermatol. 2009;26:529-35.

263) Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, Gottrup F, Gurtner GC, Longaker MT. Human skin wounds: a major and snowballing threat to public health and the economy.


264) Hu S, Parmet Y, Allen G, Parker DF, Ma F, Rouhani P, Kirsner RS. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida.

Arch Dermatol. 2009;145:1369-74.

265) Pieper B, Templin TN, Kirsner RS, Birk TJ. Substance abuse and chronic venous disorders.

West J Nurs Res. 2009;31;1092-3.

266) Joshi SS, Romanelli P, Kirsner RS. Sarcoidosis mimicking a venous ulcer: a case report.Ostomy Wound Manage. 2009;55:46-8.

267) Kirsner RS Dermatology hospitalists revisited. J Amer Acad Derm 2010 ;62:148-9.

268) Kirsner RS , Heffernan MP, Antaya R: Safety and Efficacy of Tacrolimus Ointment Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids: A Subset Analysis of 3 Multicenter, Randomized Blinded, Therapeutic Trials

Acta Derm Venereol. 2010;90:58-64

269) Rouhani P, Arheart KL, Kirsner RS. Differences in melanoma outcomes among Hispanic Medicare enrollees.

J Am Acad Dermatol. 2010;62:768-76

33

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kirsner%20RS%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Birk%20TJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Templin%20TN%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pieper%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

270) Kim N. Kirsner RS: Nicotinamide in DermatologyExpert Review in Dermatology 2010

271) Weinstein DA, Kirsner RS. Refractory ulcers: the role of tumor necrosis factor-alpha.J Am Acad Dermatol. 2010;63:146-54.

272) Snyder RJ, Kirsner RS, Warriner III RA, Lavery LA, Hanft JR, Sheehan P. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes.

Ostomy Wound Manage. 2010;56:S1-S24.

273) Vivas AC, Escandon J, Kirsner RS. Refractory erythromelalgia of the ears: response to mexiletine.

Am J Otolaryngol. 2010 Apr 12.

274) Rouhani P, Pinheiro PS, Sherman R, Arheart K, Fleming LE, Mackinnon J, Kirsner RS. Increasing rates of melanoma among nonwhites in Florida compared with the United States.


275) Federman DG, Kravetz JD, Kashaf SS, Kirsner RS. Pokes, papules, plaques.Am J Med. 2010;123:514-6.

276) Kirsner RS. Biological agents for chronic wounds.Am J Clin Dermatol. 2010;11 Suppl 1:23-5.

277) Patel SS, Nijhawan RI, Stechschulte S, Parmet Y, Rouhani P, Kirsner RS, Hu S. Skin cancer awareness, attitude, and sun protection behavior among medical students at the University of Miami Miller School of Medicine

Arch Dermatol. 2010;146:797-800.

278) Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010;23):375-88.

279) Pieper B, Templin TN, Kirsner RS, Birk TJ. The impact of vascular leg disorders on physical activity in methadone-maintained adults.

Res Nurs Health. 2010;33:426-40.

280) Kirsner RS , Warriner R, Michela M, Stasik L, Freeman K. Advanced biological therapies for diabetic foot ulcers.

34

Arch Dermatol. 2010;146:857-62.

281) Rouhani P, Kirsner RS, Amado A, Fleming LE, Nouri K, Jacob SE. Knowledge of Surgery-Related Allergic Contact Dermatitis among Florida Dermatological Surgeons: A Pilot Study

J Clin Aesthet Dermatol. 2009;2:33-6.

282) Kirsner RS , Ma F, Fleming LE, Federman DG, Trapido E, Duncan R, Rouhani P, Wilkinson JD. Earlier stage at diagnosis and improved survival among Medicare HMO patients with breast cancer.

J Womens Health (Larchmt). 2010;19:1619-24.

283) Lebrun E, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers.


284) Shelling ML, Federman DG, Kirsner RS. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers.

Arch Dermatol. 2010;146:1026-9.

285) Pieper B, Templin TN, Kirsner RS, Birk TJ. Injection-related venous disease and walking mobility.

J Addict Dis. 2010;29:481-92.

286) Vivas A, Choudhary S, Escandon J, Tang J, Lebrun E, Kirsner RS. New therapies for treatment of diabetic foot ulcers: a review of current clinical trials.

Surg Technol Int. 2010;20:83-96.

287) Lee KC, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.


288) Fan K, Tang J, Escandon J, Kirsner RS. State of the art in topical wound-healing products.

Plast Reconstr Surg. 2011;127 Suppl 1:44S-59S

289) Yin N, Parker DF, Hu S, Kirsner RS. Geographic Distribution of Melanoma in Miami-Dade County, Florida.

Arch Dermatol. 2011 Jan 17

35

290) Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment.


291) Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparison of negative pressure wound therapy with an ultraportable mechanically powered device vs. traditional electrically powered device for the treatment of chronic lower extremity ulcers: a multicenter randomized-controlled trial.


292) Blume P, Driver VR, Tallis AJ, Kirsner RS, Kroeker R, Payne WG, Wali S, Marston W, Dove C, Engler RL, Chandler LA, Sosnowski BK. Formulated collagen gel accelerates healing rate immediately after application in patients with diabetic neuropathic foot ulcers.


293) Patel RV, Shelling ML, Prodanovich S, Federman DG, Kirsner RS. Psoriasis and Vascular Disease-Risk Factors and Outcomes: A Systematic Review of the Literature.

J Gen Intern Med. 2011;26:1036-49.

294) Viola KV, Tolpinrud, WL, Gross CP, Kirsner RS, Imaeda S, Federman, DG: Outcomes of Referral to Dermatology for “Suspicious” Lesions: Implications for Teledermatology

Arch Derm 2011;147:556-560.

295) Escandon J, Vivas AC, Tang J, Rowland KJ, Kirsner RS. High Mortality in Patients with Chronic Wounds


296) Stechschulte SA, Kirsner RS, Federman DG. Sunscreens for non-dermatologists: What you should know when counseling patients

Postgrad Med. 2011;123:160-7.

297) Tolpinrud WL, Viola KV, Kirsner RS, Gross CP, Imaeda S, Federman DG. Nondermatologists' use of predictive terms for a potentially malignant lesion

South Med J. 2011;104:477-81.

298) Vivas AC, Maderal AD, Than MP, Kirsner RS. Letter: Designing clinical trials to bring wound products to market.

Int Wound J. 2011 Dec 14.

299) Tang JC, Dosal J, Kirsner RS. Topical timolol for a refractory wound.

36

http://www.ncbi.nlm.nih.gov/pubmed/22093053













Dermatol Surg. 2012;38:135-8.

300) Vivas A, Tang JC, Escandon J, Kirsner RS. Postradiation chronic scalp ulcer: a challenge for wound healing experts.

Dermatol Surg. 2011;37:1693-6

301) Hu S, Kirsner RS. Suboptimal skin cancer screening and delayed melanoma diagnosis in Hispanics: comment on "Cutaneous melanoma and other skin cancer screening among Hispanics in the United States".


302) Nunes AP, Lapane KL, Weinstock MA; VATTC Trial Group. Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Pharmacoepidemiol Drug Saf. 2011;20:922-9.

303) Shelling ML, Kirsner RS. Lack of appropriate screening for the metabolic syndrome in patients with psoriasis risks underrecognition and undertreatment of important comorbidities: comment on "Prevalence of the metabolic syndrome in psoriasis".


304) Nusbaum AG, Kirsner RS, Charles CA. Biofilms in dermatology.

Skin Therapy Lett. 2012;17:1-5.

305) Pastar I, Khan AA, Stojadinovic O, Lebrun EA, Medina MC, Brem H, Kirsner RS, Jimenez JJ, Leslie C, Tomic-Canic M. Induction of specific micro Ribonucleic acids (miRNAs) inhibits cutaneous wound healing.

J Biol Chem. 2012;287:29324-35

306) Tang JC, Vivas A, Rey A, Kirsner RS, Romanelli P. Atypical ulcers: wound biopsy results from a university wound pathology service .


307) Tang L, Sierra JO, Kelly R, Kirsner RS, Li J. Wool-derived keratin stimulates human keratinocyte migration and types IV and VII collagen expression.

Exp Dermatol. 2012;21:458-60.

37



















308) Weiss J, Kirsner RS, Hu S. Trends in primary skin cancer prevention among US Hispanics: a systematic review.

J Drug in Dermatol 2012;11:580-6

309) Pastar I, Ramirez H, Stojadinovic O, Brem H, Kirsner RS, Tomic-Canic M. Micro-RNAs: New Regulators of Wound Healing.

Surg Tech Int 2011;XXI:51-60

310) Fernandez CA, McClure LA, LeBlanc WG, Clarke TC, Kirsner RS, Arheart KL, Lee DJ. A comparison of Florida skin cancer screening rates with those in the rest of the United States.


311) Pechter PM, Gil J, Valdes J, Tomic-Canic M, Pastar I, Stojadinovic O, Kirsner RS, Davis SC. Keratin dressings speed epithelialization of deep partial-thickness wounds.


312) Gordon KA, Lebrun EA, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers.

Skinmed. 2012;10:24-6.

313) Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R, Eilers D, Naylor M, Kirsner R, Kalivas J, Cole G, Vertrees JE; Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.

J Invest Dermatol. 2012;132:1583-90.

314) Escandon J, Vivas AC, Perez R, Kirsner R, Davis S. A prospective pilot study of ultrasound therapy effectiveness in refractory venous leg ulcers.

Int Wound J. 2012 Feb 1. doi: 10.1111/j.1742-481X.2011.00921.x.

315) Than MP, Smith RA, Cassidy S, Kelly R, Marsh C, Maderal A, Kirsner RS. Use of a keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa.

J Dermatolog Treat. 2012 Jan 21. [Epub ahead of print]

38

















316) Tang JC, Marston WA, Kirsner RS. Wound Healing Society (WHS) venous ulcer treatment guidelines: What's new in five years?


317) Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: A multicenter randomized controlled trial.

Wound Repair Regen. 2012;20(3):332-41.

318) Kirsner RS , Marston WA, Snyder RJ, Lee TD, Cargill DI, Slade HB.Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

Lancet. 2012;380:977-85

319) Vivas AC, Maderal AD, Kirsner RS. Giant ulcerating squamous cell carcinoma arising from linear porokeratosis : a case study.


320) Na CR, Wang S, Kirsner RS, Federman DG. Elderly adults and skin disorders: common problems for nondermatologists.

South Med J. 2012;105):600-6.

321) Eaglstein WH, Kirsner RS, Robson MC. Food and Drug Administration (FDA) drug approval end points for chronic cutaneous ulcer studies.


322) Maderal AD, Vivas AC, Zwick TG, Kirsner RS. Diabetic foot ulcers: evaluation and management.

Hosp Pract (Minneap). 2012;40:102-15.

323) Maderal AD, Vivas AC, Eaglstein WH, Kirsner RS. The FDA and designing clinical trials for chronic cutaneous ulcers.

Semin Cell Dev Biol. 2012;23:993-9.

39



















324) Fernandez CA, McClure LA, Leblanc WG, Clarke TC, Kirsner RS, Fleming LE, Arheart KL, Lee DJ. Comparison of Florida skin cancer screening rates with those in different US regions.

South Med J. 2012;105:524-9.

325) Kirsner RS . Top-accessed article: dressings for acute and chronic wounds.

Arch Dermatol. 2012;148:1028

326) Kirsner RS , Cassidy S, Marsh C, Vivas A, Kelly RJ. Use of a keratin-based wound dressing in the management of wounds in a patient with recessive dystrophic epidermolysis bullosa.

Adv Skin Wound Care. 2012;25:400-3.

327) Nusbaum AG, Kirsner RS, Charles CA. Biofilms in dermatology.

Skin Therapy Lett. 2012;17:1-5.

328) Dyer RK, Weinstock MA, Cohen TS, Rizzo AE, Bingham SF; VATTC Trial Group. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin.


329) Than MP, Smith RA, Hammond C, Kelly R, Marsh C, Maderal AD, Kirsner RS. Keratin-based Wound Care Products for Treatment of Resistant Vascular Wounds.

J Clin Aesthet Dermatol. 2012;5:31-5

330) Lantis JC 2nd, Marston WA, Farber A, Kirsner RS, Zhang Y, Lee TD, Cargill DI, Slade HB. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.

J Vasc Surg. 2013 Apr 12. doi:pii: S0741-5214(13)00063-3. 10.1016/j.jvs.2012.12.055.

331) Mancl KA, Kirsner RS, Ajdic D. Wound biofilms: lessons learned from oral biofilms.Wound Repair Regen. 2013;21:352-62.

332) Stojadinovic O, Landon JN, Gordon KA, Pastar I, Escandon J, Vivas A, Maderal AD, Margolis DJ, Kirsner RS, Tomic-Canic M. Quality assessment of tissue specimens for studies of diabetic foot ulcers.

Exp Dermatol. 2013;22:216-8.

40















333) Kirsner RS , Slade HB. Allogeneic fibroblasts and keratinocytes for venous leg ulcers - Authors' reply.

Lancet. 2013;381:372

334) Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial. Xiong MY, Rizzo AE, Cohen TS, Dyer RK, Korgavkar K, Bingham SF, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention(VATTC) Trial Group.

J Invest Dermatol. 2013;133):1521-32

335) Eaglstein WH, Kirsner RS. Expectations for comparative effectiveness and efficacy research: with welcomed questions may come unwelcome answers.

JAMA Dermatol. 2013;149:18-9.

336) Vitiello M, Miteva M, Romanelli P, Castaneda J, Garces-Milanes D, Kirsner R, Kerdel FA. Pityriasis rubra pilaris: was it the first manifestation of colon cancer in a patient with pre-existing psoriasis?

J Am Acad Dermatol. 2013;68:e43-4.

337) Stratman E, Kirsner RS, Horn TD. Maintenance of Certification in dermatology: Requirements for diplomates.

J Am Acad Dermatol. 2013 Jul;69(1):13.e1-4; quiz 17-8.

338) Maderal AD, Vivas AC, Kirsner RS. Arm dominance does not affect healing in acute wounds.

Int Wound J. 2013 May 16.

339) Stratman E, Kirsner RS, Horn TD. Maintenance of Certification in dermatology: What we know, what we don't.

J Am Acad Dermatol. 2013 Jul;69(1):1.e1-11, quiz 12.

340) Lebrun E, Kirsner RS. Frequent debridement for healing of chronic wounds.JAMA Dermatol. 2013; Sep;149(9):1059.

341) Kirsner RS, Marston WA, Snyder RJ, Lee TD, Cargill DI, Zhang Y, Dickerson JE Jr, Slade HB. Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A 6-month follow-up.

Wound Repair Regen. 2013; Sep-Oct;21(5):682-7.

342) Pieper B, Kirsner RS. Pressure ulcers: even the grading of facilities fails.Ann Intern Med. 2013 Oct 15;159(8):571-2.

41



















343) Richmond NA, Lamel SA, Davidson JM, Martins-Green M, Sen CK, Tomic-Canic M, Vivas AC, Braun LR, Kirsner RS. US-National Institutes of Health Funded Research for Cutaneous Wounds in 2012.

Wound Repair Regen. 2013 Nov-Dec;21(6):789-92.

344) Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado RP, Senet P, Callen JP, Philip TJ, Romanelli M, Kirsner RS. Vasculopathy: An in Depth Analysis Using a Modified Delphi Approach.

JAAD. 2013;69:1033-1042.e1.

345) Kirsner RS , Bohn G, Driver VR, Mills JL Sr, Nanney LB, Williams ML, Wu SC. Human acellular dermal wound matrix: evidence and experience.

Int Wound J. 2013 Nov 28. doi: 10.1111/iwj.12185.

346) Stojadinovic O, Yin N, Lehmann J, Pastar I, Kirsner RS, Tomic-Canic M. Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome.

Immunol Res. 2013 Nov 26.

347) Criado PR, Alavi A, Halpem I, Sotto MN, Kirsner RS. Unilateral Livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.

Int J Low Extrem Wounds. 2013 Dec;12(4):306-9.

348) Federman DG, Kirsner RS, Viola KV. Skin cancer screening and primary prevention: facts and controversies.

Clin Dermatol. 2013 Dec;149(12):1400-2.

349) Richmond NA, Vivas AC, Kirsner RS. Topical and biologic therapies for diabetic foot ulcers.

Med Clin North Am. 2013;97:883-98.

350) Braun LR. Lamel SA. Richmond NA. Kirsner RS. Topical Timolol for Recalcitrant Wounds,

JAMA Dermatol. 2013 Dec;149(12):1400-2.

351) Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.

42










J Am Acad Dermatol. 2013 Dec;69(6):1033-1042.e1.

352) Richmond NA, Lamel SA, Vivas AC, Braun LR, Cucalon J, Block SG, Kirsner RS. A Retrospective Evaluation of Patient Primary Non-Adherence to Treatments in Dermatology.

JAAD 2014 Jan;70(1):201-3.

353) Alavi A. Sibbald RG. Mayer D, Goodman L, Botros M, Armstrong DG, Woo KY, Boeni T, Ayello EA, Kirsner RS. Part I :The pathophysiology and prevention of Diabetic foot ulcer

JAAD 2014 Jan;70(1):1.e1-18; quiz 19-20.

354) Alavi A. Sibbald RG. Mayer D, Goodman L, Botros M, Armstrong DG, Boeni T, Woo KY, Ayello EA , Kirsner RS. Part II: The Management of Diabetic foot ulcers.

JAAD 2014 Jan;70(1):21.e1-24; quiz 45-6.

355) Lamel SA, Richmond NA, Braun LR, Vivas AC, Kirsner RS. The Characterization of Indoor Tanning Facilities in Florida.

JAMA Dermatology 2014 Feb;150(2):209-10.

356) Batzer AT, Marsh C, Kirsner RS. The use of keratin-based wound products on refractory wounds.

Int Wound J. 2014 Feb 28. doi: 10.1111/iwj.12245. [Epub ahead of print]

357) Sharaf MA, Romanelli P, Kirsner R, Miteva M. Angioinvasive Lymphomatoid Papulosis: Another Case of a Newly Described Variant.

Am J Dermatopathol. 2014 Mar;36(3):e75-7.

358) Kirsner RS , Margolis DJ. Stockings before bandages: an option for venous ulcers.Lancet. 2014 Mar 8;383(9920):850-1.

359) Hu S, Sherman R, Arheart K, Kirsner RS. Predictors of neighborhood risk for late-stage melanoma: addressing disparities through spatial analysis and area-based measures.

J Invest Dermatol. 2014 Apr;134(4):937-45.

360) Yim E, Vivas A, Maderal A, Kirsner RS: Neuropathy and Ankle Mobility Abnormalities in Patients with Chronic Venous Disease

JAMA Dermatology 2013. 2014 Apr;150(4):385-9.

43




361) Criado PR, Alavi A, Kirsner RS. Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers.

Int J Low Extrem Wounds. 2014;13:130-134.

362) Baquerizo Nole KL, Yim E, Van Driessche F, Davidson JM, Martins-Green M, Sen CK, Tomic-Canic M, Kirsner RS. Wound research funding from alternative sources of federal funds in 2012.


363) Marston WA, Sabolinski ML, Parsons NB, Kirsner RS. Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers.


364) Baquerizo Nole KL, Kirsner RS. Advanced wound care therapies in non-healing lower extremity ulcers: high expectations, low evidence.

Evid Based Med. 2014;19:91.

365) Federman DG, Kirsner RS, Concato J. Sunscreen counseling by US physicians.

JAMA. 2014;312:87-8.

366) Kirsner RS. Compression of venous ulcers: standardizing standard care.


367) Braun LR, Fisk WA, Lev-Tov H, Kirsner RS, Isseroff RR. Diabetic foot ulcer: an evidence-based treatment update.

Am J Clin Dermatol. 2014;15:267-81.

368) Yim E, Richmond NA, Baquerizo K, Van Driessche F, Slade HB, Pieper B, Kirsner RS. The effect of ankle range of motion on venous ulcer healing rates.


369) Yim E, Sinha V, Diaz SI, Kirsner RS, Salgado CJ. Wound healing in US medical school curricula.


44

370) Richmond NA, Lamel SA, Braun LR, Vivas AC, Serena T, Kirsner RS. Epidermal grafting using a novel suction blister-harvesting system for the treatment of pyoderma gangrenosum.

JAMA Dermatol. 2014;150:999-1000.

371) Yim E, Van Driessche F, Baquerizo Nole KL, Kirsner RS. Patient self-assessment of chronic wounds.


372) Adler BL, Krausz AE, Tian J, Nosanchuk JD, Kirsner RS, Friedman AJ. Modifiable lifestyle factors in psoriasis: screening and counseling practices among dermatologists and dermatology residents in academic institutions.

J Am Acad Dermatol. 2014;71:1028-9

373) Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS. Atrophie blanche: is it associated with venous disease or livedoid vasculopathy?

Adv Skin Wound Care. 2014;27:518-24; quiz 525-6.

374) Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH,

Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K. Chronic Wound Repair and Healing in Older Adults: Current Status and Future Research.

Wound Repair Regen. 2015 23:1-13.J Am Geriatr Soc. 2015 63:427-38.

375) Baquerizo Nole KL, Yim E, Van Driessche F, Kirsner RS. Educational Interventions in Venous leg ulcer patients.


376) Yim E, Kirsner RS, Gailey RS, Mandel DW, Chen SC, Tomic-Canic M. Effect of Physical Therapy on Wound Healing and Quality of Life in Patients With Venous Leg Ulcers: A Systematic Review.

JAMA Dermatol. 2015;151:320-7

377) Jozic I, Stojadinovic O, Kirsner RS, Tomic-Canic M. Stressing the steroids in skin: paradox or fine-tuning?

45



J Invest Dermatol. 2014 Dec;134(12):2869-72.

378) Kirsner RS , Baquerizo Nole KL, Fox JD, Liu SN. Healing refractory venous ulcers: new treatments offer hope.

J Invest Dermatol. 2015 Jan;135(1):19-23

379) Gist DL, Bhushan R, Hamarstrom E, Sluka P, Presta CM, Thompson JS, Kirsner RS. Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasis.


380) Baquerizo Nole KL, Kirsner RS. Hair follicles and their potential in wound healing.

Exp Dermatol. 2015 Feb;24(2):95-6

381) Jozic I, Stojadinovic O, Kirsner RS, Tomic-Canic M. Skin under the (Spot)-Light: Cross-Talk with the Central Hypothalamic-Pituitary-Adrenal (HPA) Axis.


382) Criado PR, de Souza Espinel DP, Sakai Valente NY, Alavi A, Kirsner RS. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol.

Dermatol Ther. 2015 Mar 30. doi: 10.1111/dth.12225. [Epub ahead of print]

383) Baquerizo Nole KL, Fox JD, Kirsner RS. In Search of a Proportionate Funding in Medicine.

JAMA Dermatol. 2015 Feb 25. doi: 10.1001/jamadermatol.2014.5112. [Epub ahead of print]

384) Marston WA, Armstrong DG, Reyzelman AM, Kirsner RS. A Multicenter Randomized Controlled Trial Comparing Treatment of Venous Leg Ulcers Using Mechanically Versus Electrically Powered Negative Pressure Wound Therapy.

Adv Wound Care (New Rochelle). 2015;4:75-82.

OTHER WORKS, Journal of Investigative Dermatology Journal Club

1) Paul R. Bergstresser, Kirsner RS: Introducing JID Journal ClubJ Invest Dermatol 2007;127:2067.

2) Kirsner RS, Hu S: Hand eczema prognosis.J Invest Dermatol. 2007;127:2072

3) Kirsner RS, Hu S: Recessive Dystrophic Epidermolysis Bullosa andSquamous-Cell Carcinoma: the Role of Type VII Collagen

J Invest Dermatol. 2007;127:2292

46










4) Blyumin M, Hu S, Kirsner RS: Filaggrin Gene Mutations Mediate Severity of AlopeciaAreata When Associated with Atopic Dermatitis

J Invest Dermatol 2007;127:2494.

5) Blyumin M, Hu S, Kirsner RS: Insight into photocarcinogenesis.J Invest Dermatol. 2007;127:2700.

6) Rajpara V, Hu S, Kirsner RS: The role of Gadd45a in the survival of melanocytes and melanoma cells.

J Invest Dermatol. 2008 ;128:4.

7) Kim N, Yang A, Kirsner RS: Topical nicotinamide prevents UV immunosuppression.J Invest Dermatol. 2008;128:250.

8) Kim NH, Yang A, Kirsner RS: Antibody response in endemic pemphigus foliaceus.J Invest Dermatol. 2008;128:498

9) Romagosa Y, Hu S, Kirsner RS: Chronic diseases and non-melanoma skin cancer: is there an association?


10) Romagosa Y, Hu S, Kirsner RS: Wound Healing Without Hair J Invest Dermatol. 2008 128:1058.

11) Martin LK, Hu S, Kirsner RS: Catestatin: A New Member of the Cutaneous Defense System

J Invest Dermatol. 2008;128:1350.

12) Zell D, Hu S Kirsner RS: Genetic alterations in psoriasis.J Invest Dermatol. 2008;128:1614

13) Zell D, Hu S, Kirsner RS. A paradigm shift in the mechanisms of graft rejection.

J Invest Dermatol. 2008;128(8):1874.

14) Poocheron V, Hu S, Kirsner RS. Allogeneic cell therapy for epidermolysis bullosa.J Invest Dermatol. 2008;128:2134.

15) Fernandez A, Hu S, Kirsner RS. Sirolimus: A potential chemopreventative agent. J Invest Dermatol. 2008;128:2352.

16) Keegan BR, Romagosa Y, Kirsner RS: MRSA in Dermatology J Invest Dermatol 2008; 128: 2566;

47

17) Tzu J, Kim N, Kirsner RS. Why Rituximab works.J Invest Dermatol. 2008;128:2744.

18) Tzu J, Romagosa Y, Kirsner RS: Who Will Develop Pemphigus Foliaceus? J Invest Dermatol. 2009 Jan;129(1):6

19) Marchione R, Kim N, Kirsner RS. Pseudoxanthoma elasticum: new insights.J Invest Dermatol. 2009;129:258.

20) Marchione R, Kim N, Kirsner RS. Epidermal growth factor receptor regulates skin nerve outgrowth and branching.


21) Bouzari N, Kim N, Kirsner RS. Defense of the skin with LL-37.J Invest Dermatol. 2009;129:814.

22) Bouzari N, Romagosa Y, Kirsner RS. Green Tea Prevents Skin Cancer by Two Mechanisms


23) Rosso R, Romagosa Y, Kirsner RS: Progression of NRAS and BRAF mutations in cutaneous melanoma.


24) Rosso R, Kim N, Kirsner RS. Vitamin D intake and melanoma risk. J Invest Dermatol. 2009 ;129:1598.

25) Green J, Kim N, Kirsner RS. Defining Ro positivity.J Invest Dermatol. 2009;129:1848.

26) Rico T, Green J, Kirsner RS. Vascular endothelial growth factor delivery via gene therapy for diabetic wounds: first steps


27) Rico T, Marchione R, Kirsner RS. Vascular disease in psoriasis.J Invest Dermatol. 2009;129:2327.

28) Rico T, Green J, Kirsner RS. Novel antiviral therapy based on innate immunity.J Invest Dermatol. 2009 ;129:2540.

48

29) Vega J, Tzu J, Kirsner RS. Re-examining cutaneous immunity.

J Invest Dermatol. 2009; 129

30) Camacho I, Tzu J, Kirsner RS: The skin as an endocrine target.J Invest Dermatol. 2010;130:6.

31) Camacho I, Tzu J, Kirsner RS. Regulation of vitamin D production is independent of skin color.


32) Price CJ, Green J, Kirsner RS. Mastocytosis in children is associated with mutations in c-KIT.


33) Price CJ, Tzu J, Kirsner RS. Unraveling the role of desmosomal proteins.J Invest Dermatol. 2010;130:916.

34) Sulewski R, Kirsner RS. The multipotent nature of hair bulge cells.J Invest Dermatol. 2010;130:1198

35) Barron GS, Kirsner RS. Xeroderma pigmentosum: a heterogeneous disease with pockets of homogeneity.


36) Ballard CJ, Elgart GW, Kirsner RS. Help in the diagnosis of melanoma?J Invest Dermatol. 2010;130:1763.

37) Stirling L, Kirsner RS. Evidenced Based Pemphigus Treatment?J Invest Dermatol. 2010;130:1963

38) Stirling L, Kirsner RS Is Your Patient with Neurofibromatosis Likely to Develop A Malignancy?

J Invest Dermatol. 2010;130(9):2160

39) Keaney TC, Kirsner RS. Why is Your Sunscreen Not Working?J Invest Dermatol. 2010;130(10):2347.

40) Keaney TC, Kirsner RS. New Insights Into the Mechanism of Narrow Band UVB for Psoriasis

J Invest Dermatol. 2010;130(10):2534.

41) Lanuti EL, Kirsner RS. Effects of Pollution on Skin Aging

49


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tzu%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Camacho%20I%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract


42) Lanuti EL, Wikramanayake TC, Kirsner RS. Overcoming obstacles for gene therapy for recessive dystrophic epidermolysis bullosa.


43) Aber C, Jimenez J, Kirsner RS. Hair and Wound Healing. Anagen Gets an “a”.J Invest Dermatol. 2011;131:278.

44) Aber C, Kirsner RS. Restoring tacrolimus-induced impaired barrier function.J Invest Dermatol. 2011;131:554.

45) Herschthal J, Kirsner RS. Potent Topical Steroids during Pregnancy Affect Newborn Birth Weight.


46) Chimento SM, Kirsner RS. Understanding the Role of c-Jun and Jun B Transcription Factors in Skin Cancer Developments.


47) Chen AF, Kirsner RS. Mechanisms of drug action: the potential of dimethylfumarate for the treatment of neoplasms.


48) Bard S, Kirsner RS. Do nonsteroidal anti-inflammatory drugs prevent melanoma?J Invest Dermatol. 2011;131:1394.

49) Bard S, Kirsner RS. Capitalizing on mechanisms of skin cancer development?J Invest Dermatol. 2011;131:1592

50) Shelling ML, Kirsner RS. Variability in patients with psoriasis: insights into the genotype-phenotype relationship


51) Miner A, Kirsner RS Diabetic control affects healing rates in neuropathic and vasculopathic patients


52) Miner A, Kirsner RS. Epitope spreading in bullous pemphigoid: what does it mean?J Invest Dermatol. 2011;131:2165.

53) Dosal J, Grichnik JM, Kirsner RS. Local actions of thyrotropin-releasing hormone regulate hair color.

50













54) Dosal J, Kirsner RS. Reducing the incidence and severity of acute graft-versus-host disease.


55) Schwartzfarb E, Kirsner RS. Understanding scarring: scarless fetal wound healing as a model.


56) Schwartzfarb E, Kirsner RS. Insights in Behçet's disease: has a target antigen been identified?


57) Spock C, Kirsner RS. An itchy mouse: a potential model of atopic dermatitis. J Invest Dermatol. 2012 ;132:1064. doi: 10.1038/jid.2012.49.

58) Spock C, Kirsner RS. Second chances for skin: correcting genetic mutations. J Invest Dermatol. 2012 ;132:1316.

OTHER WORKS, Journal of Investigative Dermatology Journal Club

1) Viera M, Kirsner RS. JID VisualDx Quiz: February 2013.J Invest Dermatol. 2013 May;133(5):e1.

2) Vega A, Kirsner RS. JID VisualDx Quiz: March 2013.J Invest Dermatol. 2013 May;133(5):e2.

3) Nolan B, Kirsner RS. JID VisualDx Quiz: April 2013.J Invest Dermatol. 2013 May;133(5):e3

4) Amini S, Kirsner RS. JID VisualDx Quiz: May 2013.J Invest Dermatol. 2013 May;133(5):e4.

5) Styperek A, Kirsner RS. JID VisualDx Quiz: July 2013.J Invest Dermatol. 2013 Jul;133(7):e6.

6) Styperek A, Kirsner RS. JID VisualDx Quiz: August 2013.J Invest Dermatol. 2013 Aug;133(8):e7.

7) Winslow CY, Kirsner RS JID VisualDx quiz: October 2013.

51
















J Invest Dermatol. 2013 Oct;133(10):e10

8) Choudhary S, Kirsner RS. JID VisualDx Quiz: December 2013.J Invest Dermatol. 2013 Dec;133(12):e11.

9) Choudhary S, Kirsner RS. JID VisualDx Quiz: January 2014.J Invest Dermatol. 2014 Jan;134(1):e12.

10) Freedman, JR, Kirsner RS. JID VisualDx Quiz: February 2014.J Invest Dermatol. 2014 Feb;134(1):e13.

11) Weiss J, Kirsner RS. JID VisualDx Quiz: March 2014. Thermal burn. Burn wounds induce elevated catecholamines. Prolonged neutrophil lifespan delays healing.

J Invest Dermatol. 2014 Mar;134(3):e14.

12) Weiss J, Kirsner RS. JID VisualDx Quiz: April 2014. J Invest Dermatol. 2014 Apr;134(3):e15

13) Patel T, Kirsner RS.JID VisualDx quiz: May 2014.J Invest Dermatol. 2014 May;134(5):e16

14) Badiavas A, Kirsner RS. JID VisualDx quiz: July 2014. Graft-versus-host disease.J Invest Dermatol. 2014 Jul;134(7):e18

15) Badiavas A, Kirsner RS. JID VisualDx Quiz: August 2014: pemphigus foliaceus.J Invest Dermatol. 2014 Aug;134(8):e19

16) Lattouf C, Kirsner RS. JID VisualDx Quiz: September 2014.J Invest Dermatol. 2014 Sep;134(9):e12.

17) Ollague JE, Kirsner RS. JID VisualDx quiz: October 2014. Scar.J Invest Dermatol. 2014 Oct;134(10):e21.

18) Ollague JE, Kirsner RS. JID VisualDx Quiz: November 2014.J Invest Dermatol. 2014 Nov;134(11):e22

19) Shabbir A, Kirsner RS. JID VisualDx quiz: December 2014.

J Invest Dermatol. 2014 Dec;134(12):e23

20) Shabbir A, Kirsner RS.JID VisualDx Quiz: January 2015.

J Invest Dermatol. 2015 Jan;135(1):e24.

21) Nichols A, Kirsner RS. JID VisualDx Quiz: February 2015. J Invest Dermatol. 2015 Feb;135(2):e25.

52








22) Ross A, Kirsner RS. JID VisualDx Quiz: March 2015.J Invest Dermatol. 2015 Mar;135(3):e26.

23) Ross A, Kirsner RS. JID VisualDx Quiz: April 2015.J Invest Dermatol. 2015 Apr;135(4):e27.

24) Vivas AC, Kirsner RS. JID VisualDx Quiz: May 2015.J Invest Dermatol. 2015 May;135(5):e28.

OTHER WORKS, Archives of Dermatology Practice Gaps

1) Vivas A, Kirsner RS. Practice gaps--Submitting clinical photographs to dermatopathologists to facilitate interpretations: comment on "the utility of clinical photographs in dermatopathologic diagnosis: a survey study".

Arch Dermatol. 2010;146:1308-9.

2) Shelling ML, Kirsner RS. Failure to counsel patients with psoriasis to decrease alcohol consumption (and smoking).

Arch Dermatol. 2010;146:1370.

3) Shelling ML, Kirsner RS. Lack of appropriate screening for the metabolic syndrome in patients with psoriasis risks underrecognition and undertreatment of important comorbidities: comment on "prevalence of the metabolic syndrome in psoriasis".


4) Shasa Hu S, Kirsner RS: Practice Gap: Suboptimal skin cancer screening may contribute to delayed melanoma diagnosis in Hispanics

Arch Dermatol. 2011;147:745-6

5) Shelling ML, Kirsner RS. Gaining insights into the relationship of obesity, weight loss, and psoriasis.


OTHER WORKS, PUBLICATIONS AND ABSTRACTS

1) Sawaya ME, Kirsner RS, Nemeth AJ, Weiss DS, Hsia SL: Elevated type II glucocorticoid receptor binding in keloids and hypertrophic scars.

53






http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kirsner%20RS%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vivas%20A%22%5BAuthor%5D




JID 94, 1990. Clin. Res. 38; 1990.

2) Sawaya ME, Price VH, Harris KA, Kirsner RS, Hsia SL: Human hair follicle aromatic activity in females with androgenetic alopecia.

JID 94; 1990. Clin. Res. 38; 1990.

3) Kirsner RS, Katz MH, Falanga V: Hypoxia induced stimulation of single fibroblast growth in vitro and its inhibition by suramin.

JID 96; 1991. Clin. Res. 39; 1991.

4) Katz MH, Alvarez AF, Kirsner RS, Falanga V: Endothelin-1 is a growth factor for fibroblasts.

JID 96; 1991. Clin. Res. 39; 1991.

5) Kirsner RS, Pardes JB, Ochoa S, Martin TA, Falanga V: Oxygen tension controls collagen type I transcription.

JID 98; 1992. Clin. Res. 40; 1992.

6) Pardes JB, Kirsner RS, Ochoa S, Martin TA, Falanga V: TGF- beta 1 is a potent inhibitor of human dermal fibroblasts. JID 98; 1992. Clin. Res. 40; 1992.

7) Carson PA, Kirsner RS, Pardes JB, Falanga V: Evaluation of sorbsan in the treatment of venous ulcers.

Wounds 1992; 4: 30-31.

8) Higley H, Ksander G, Gerhart C, Kirsner RS, Falanga V: Immunocytochemical analysis of growth factor and growth factor response cells in chronic venous stasis ulcers.

Wounds 1992; 4: 33-34.

9) Helfman T, Kirsner RS, Pardes J, Takagi H, Ochoa S, Martin T, Falanga V: Transcriptional regulation of TGF-Beta 1 (TGF-Beta) and alpha 1 (1) Procollagen gene in hypoxic fibroblasts.

JID 100; 1993. Clin. Res. 41; 1993.

10) Kirsner RS, Falanga V: Features of an autoimmune process in mid-dermal elastolysis. In: The Yearbook of Dermatology 1993. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.

11) Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V: Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. In: The Yearbook of Dermatology 1994. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.

12) Bieley HC, Kirsner RS, Reyes BA, Garland LD: The use of Mohs Micrographic Surgery for determination of residual tumors in incompletely excised basal cell carcinomas. In: The Yearbook of Dermatologic Surgery 1994. Eds. Neil A. Swanson, Richard G. Glogau,

54

and Stuart J. Salashe.

13) Falanga V, Eaglstein WH, Kirsner RS: Recurrent Cellulitis (Letter Reply). J Am Acad Dermatol 1994; 30: 676.

14) Machler BC, Kirsner RS, Elgart GW: Routine histology for the diagnosis of onychomycosis: Evaluation of sensitivity and specificity.

J Cutan Pathol 1995; 22: 71

15) Sherendiah S, Kirsner RS, Valenzuela R: Epidermolysis BullosaAcquisita.

Immunopathology Check Sample No IP 95-3 (IP-III) Am Soc Clin Pathol 1995.

16) Kirsner RS: Systemic agents which affect wound healing.J Dermatol Treat 1996; 7:62

17) Kirsner RS: Gene Therapy.J Dermatol Treat 1996; 7: 60.

18) Hurwitz D, Kirsner RS, Falanga V, Elgart GW: The pathologic spectrum of lipodermatosclerosis.

J Cutan Pathol 1996; 23:78.

19) Federman DG, Hogan D, Taylor JR, Caralis PV, Kirsner RS: A comparison of diagnosis, evaluation and treatment of patients with dermatologic disorders. In: The Yearbook of Dermatology 1996. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.

20) Kirsner RS, Mata SM, Falanga V, Kerdel FA: Split-thickness skin grafting of leg ulcers. The University of Miami Dermatology's Experience (1990-1993). In: The Yearbook of Dermatology 1996. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.

21) Federman DG, Concato J, Caralis PV, Hunkele G, , Kirsner RS: The frequency of skin cancer screening examinations compared to other cancer screening examinations by primary care providers.


22) Kirsner RS, Federman DG: Lack Of Correlation Between Internists’ Ability in Dermatology And Their Patterns Of Treating Patients With Skin Disease.

Amer J Managed Care 1997;3:390.

23) Federman DG, Kirsner RS: Primary care in dermatology (Letter).J Am Acad Dermatol 1997;37:668.

24) Kirsner RS: Outcomes: Are clinicians ready.

55


25) Kirsner RS: Apligraf treatment for acute wounds.J Dermatol 1998;108:486.

26) Elgart G, Valencia IC, Hurwitz D, Kirsner R, Falanga V, Eaglstein WH: Lipodermatosclerosis: The histological spectrum.

J Cut Pathol 1998;25:494.

27) Kerdel FA, Kirsner RS: Who should care for hospitalized patients with severe skin disease (Letter).

Arch Dermatol 1998;134:1159.

28) Kirsner RS, Federman DG: Dermatology education for internists (Letter). Arch Int Med 1998;158:1952-1953.

29) Hanly AJ, Valencia IC, Badiavas E, Kirsner R, Elgart GW: Dual infections in an AIDS patient masquerading as squamous cell carcinoma: Light, immunohistochemical and electron microscopic evaluation.

J Cut Pathol 1998;25:497.

30) Federman DG, Kirsner RS: Skin biopsies, cutaneous disease, and primary care (Letter).Ann Int Med 1999;130:617.

31) Pacheco HA, Riley GS, Potosky S, Federman DG, Kirsner RS: Differences in melanoma stage between HMO and FFS are due to access to health care.


33) Ayyalaraju RSA, Finlay AY, Kirsner RS, Trent JT, Kerdel FA: Dermatology Inpatient Services UK/USA Comparative Study.

Br J Dermatol 1999;141(Suppl 55):79-80.

34) Kerstein MD, Kirsner RS, Norman RA, Phillips TA: How to approach acute and chronic wound healing in the elderly.

Wounds 1999; 11:145-151.

35) Ayyalaruji RS, Finlay AY, Dykes PJ, Trent JT, Kerdel FA, Kirsner RS: Dermatology inpatient services. A UK/USA comparison study.

J Invest Dermatol 2000;114: 886.

36) Eaglstein WH, Kerdel FA, Elgart GE, Kirsner RS, Muhart M: A controlled trial, LSE vs. Killed LSE, is needed (Letter Reply).

Arch Dermatol 2000;136: 555-556.

56

37) Kirsner RS, Valencia I, Falabella AF, Eaglstein WH: About the pathophysiology of venous leg ulceration (Letter Reply).

J Amer Acad Dermatol 2002;47:158.

38) Kirsner R: New approaches to a timeless dilemma.Ostomy Wound Management 2003;49:12-14.

39) Kirsner R: Wound Bed Preparation.Ostomy Wound Management 2003;Suppl Feb:2-3.

40) Trent JT, Kirsner RS, Romanelli P, Kerdel FA: Scoring with Scorten (Letter Reply)Arch Derm 2003;139:1215-1216.

41) Federman DG, Kirsner RS: A Rash Decision (letter). Ann Int Med 2003;139:869.

42) Sullivan TP, Kirsner RS: Punch technique to improve granulation over exposed tendons in chronic wounds (Letter Reply).

J Am Acad Dermatol 2004;50:e7

43) Boulton AJM, Kirsner RS, Vileikyte L: Neuropathic Diabetic Foot Ulcers (Letter Reply).New Engl J Med 2004;351:1694-1696.

44) Federman DG, Kirsner RS: Prevalence of elevated ankle brachial index (letter). Ann J Med 2006;119:96.

45) Pieper B, Kirsner RS, Templin TN, Birk TJ: Injection Drug Users in the United States, 1979-2002 (Letter).

Arch Int Med. 2007;167:1807.

46) Federman DG, Shelling ML, Kirsner RS. Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States.

Am J Med. 2010;123(12):e11;

47) Federman DG, Shelling ML, Kirsner RS. N-of-1 Trials: Not Just for Academics.J Gen Intern Med. 2011;26(2):115.

AMERICAN ACADEMY OF DERMATOLOGYPUBLICATIONS AS A MEMBER OF THE GUIDELINES/OUTCOMES COMMITTEE

1) Guidelines of care for liposuction. J Amer Acad Derm 2001;45:438-47.

57

2) Guidelines of care for primary cutaneous melanoma. J Amer Acad Derm 2001;45:579-86.

INTERNET PUBLICATIONS

1) Kirsner RS, Yang D, Kerdel FA: Admission of patients with skin disease to the hospital (Letter Reply).

J Amer Acad Derm 2001Published January 12, 2001 doi:10.1067/mjd.2001.112356

2) Richmond NA, Vivas AC. Lamel SA, Braun LR, Kirsner RS. Reducing Slippage of Multilayer Compression Bandages in Patients with a Venous Leg Ulcer and the Typical “Inverted Champagne Bottle” Leg.

Ostomy Wound Management. Published online. Feb 2013.

CME PROGRAM

1) Treadwell T, Kirsner RS: Medical Simulations in wound care management. InterMed Press, Darien, Connecticut.

2) Kerdel FA, Kirsner RS: Cutaneous and oral manifestations of HIV and AIDS. A CME Series.

COMPUTER PROGRAM

1) Kirsner RS , Anhalt GJ, Kerdel FA: Treatment with alpha-interferon associated with the development of Paraneoplastic Pemphigus. Teachings in Dermatology Volume I.

Mosby Publisher, St. Louis, 1994.

V. PROFESSIONAL

GRANTS RECEIVED

06/92 World Congress of Dermatology $ 1,000

07/95-7/98 Dermatology Foundation $ 120,000 Career Development Award For Health Care Policy

75% Effort

01/01-12/02 American Skin Association $15,000The Effect of Health Care Delivery Systems

58

On Outcomes of Patients With Melanoma 5% Effort

01/03-12/04 American Cancer Society $50,000Cancer Among Indigent Populations In South Florida:The relationship between Poverty, Cancer Rates and Medical Services5% Effort

8/03-7/04 National Cancer Institute $50,000NIH U01-CA86117 $50,000Perception of risk of skin cancer in Hispanic students5% Effort

9/04-8/09 National Cancer Institute $1,542,133R25 CA109392-01 SunSmart America: Evaluating a School Based Curriculum10% Effort

6/05-5/08 National Institutes of Health $770,980 R01 NR009264-01Effect of Drug Use on the Legs: CVI, Mobility and Pain5% Effort

7/06- 6/11 National Institute of Diabetes, Digestive $140,464and Kidney DiseasesNIH 1 RO1- DK71066-01A2Emotional distress and wound healing in diabetes5% effort

7/09- 6/11 National Institute of Arthritis, Musculoskeletal $272,516 and SkinNIAMS 1RC1DK086364-01 Development of the Cellular Biomarker for Diabetic Foot Ulcers

5% effort

7/07- 2/13 National Institute of Aging $1,250,000Bone Marrow Stem Cells and the Microenvironment of Chronic Wounds

5% effort

8/12 – 5/16 National Institutes of Nursing Research $1,720,035Micro-RNA Molecules as Regulators of Diabetic Wound Healing5% effort

59

9/12- 8/17 National Institute of Diabetes, Digestive $ 311,612and Kidney DiseasesStem cell Mobilization and Diabetic wounds 5% effort

SPONSORED CLINICAL RESEARCH STUDIES 2010-2015

A Phase III, Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Sham-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell as an Adjunct to Good Wound Care Measures in Treating Lower Extremity Chronic Ulcers. (Macrocure)

A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus

A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers. (Macrocure)

DSC127-2012-02 -A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus (Derma Sciences)

A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802247 in the Treatment of Venous Leg Ulcers >12 cm2 to 36 cm2. (Healthpoint LTD)

IN-BALANCE VLU Inflammation, Bacteria, & Angiogenesis Effects in Launching Venous Leg Ulcer Healing (Celleration, Inc.)

Phase IV Prospective, Multi-Center, Randomized, Single-Blind, Active and Standard Care-Controlled Study of DermaPure™ in Patients With "Hard to Heal" Chronic, Neuropathic Diabetic Foot Ulcers With Crossover Design for Standard Care Arm (TRx Wound Care Limited)

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers. (Tactile Medical)

An Open-label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum ( XOMA)

A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma Nevus Syndrome Patients (Genentech) Co-PI

60

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B8F852A6F25715945A70B0424E0CB4A16%5D%5D



Completed Studies:

Safety and Efficacy of HO/03/03 10ug in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers. (HealOr)

A Prospective, Multi-center, Randomized, Controlled Clinical Investigation of Dermagraft in Patients with Venous Leg Ulcers. (Advanced Biohealing)

A Prospective, Multicenter, Longitudinal, Cohort Study of Dermagraft in Subjects with Venous leg Ulcers: A long-Term Follow Up to the DEVO Trial. (Advanced Biohealing)

A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard Care in Subjects with Venous Leg Ulcers. (Skingenix)

The Mechanism of Action of Unite Biomatrix in Diabetic Foot Ulcer. (Synovis Orthopedic & Wound Care)

An Open-label, Randomized, Evaluator-Blinded Study of the Effect of Polymerized Fibrin Applied Topically Once per Week, on Healing of Induced Thermal Wounds, versus Weekly Applications of White Petrolatum- (Healthpoint, Inc.)

A Phase II Randomized, Double, Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous leg ulcers. (Healthpoint, Inc.)

A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015. (Healthpoint, Inc.)

Emotional Stress and Wound Healing in Diabetes. (NIH)

SWHI-03: A Randomized, Double-Blind, Placebo-Controlled, Single- and Double-Dose, Comparator Arm (Standard of Care), Multicenter Phase 2b Study of Topical GAM501 (Ad5PDGF-B/bovine type I collagen gel) in the Treatment of Non-Healing Diabetic Ulcers of the Lower Extremities. (Tissue Repair Comp.)

SWHI-02: A Long-Term Follow-up Study of Subjects Who Were Previously Enrolled in Tissue Repair Company-Sponsored Clinical Trials Using GAM501. (Tissue Repair Comp.)

A Randomized trial of the Flexitouch Compression System as an Adjunctive Treatment for Venous Stasis Ulcer. (Tactile Systems, Inc.)

61

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B3A9C79FB56DF884791269F2C98E68A7C%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B3A9C79FB56DF884791269F2C98E68A7C%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5BCB0A00576F82AE42B901E6F4C108FE46%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B790F8C9BE61FD0489C9B78D5490DF064%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5BC0A60F714E56A44FB488EE1ED6C2D69A%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5BC0A60F714E56A44FB488EE1ED6C2D69A%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B12C9E58E8EDE134F95705C0432DCA103%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B679F7E104E456C4EAB676B563469C500%5D%5D



https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B22EB9BB44049EE4091EDC36E4E20FA41%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B22EB9BB44049EE4091EDC36E4E20FA41%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B7F7F1E81E75FFE4AB6AA6D115F14C949%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B7F7F1E81E75FFE4AB6AA6D115F14C949%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B80156C77619D8A429EF571896686A3CD%5D%5D

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5B80156C77619D8A429EF571896686A3CD%5D%5D

A Randomized Study to Evaluate the Safety of Bone Marrow Aspirate Plus Culture Bone Marrow Cells vs. Bone Marrow Aspirate Alone vs. Cultured Bone Marrow Cells Alone in the Treatment of Chronic Wounds (NIH)

EDITORIAL RESPONSIBILITIES

Editor1997 - 1999 Co-Clinical Editor - Ostomy/ Wound Management1998 - 1999 Editor - CME supplement - Wounds1997 – 2000 Editorial Board Member- Centers for Wound Healing

Excellence1999 - 2001 Editor - Current Topics In Wound Healing - Newsletter1999 - Present Consulting Editor - Ostomy/ Wound Management2000 – Present Section Editor - Wounds2002 – Present Editor – CME supplement – Wounds2003 – Present Assistant Editor on Wound Healing – Dermatologic SurgeryJan- Feb 2007 Editor- Special issue – Clinics in DermatologyOctober 2007 Editor- Special issue – Archives of Dermatology2007- Present Associate Editor- Journal of Investigative Dermatology2009- Present Associate Section Editor- Practice Gaps – Arch Dermatology

Editorial Board1997 – Present Ostomy/Wound Management2000 - Present Wounds2003 – Present Dermatologic Surgery2003 - Present Skin and Aging2005 - Present Expert Review in Dermatology2007- 2012 Journal of Investigative Dermatology2007- Present Journal of Clinical and Aesthetic Dermatology2008 – 2013 Journal of the American Academy of Dermatology2012- Present Wound Repair and Regeneration2013 – Present JAMA Dermatology

Reviewer 1993 - Present Reviewer - Archives of Dermatology

1995 - Present Reviewer - The American Journal Managed Care1996 - Present Reviewer - Journal of the American Academy of Dermatology1997 - Present Reviewer - Advances in Skin and Wound Care1997 - Present Reviewer - Ostomy/Wound Management 1997 - Present Reviewer - Wounds1998 - Present Reviewer - American Journal of Medicine1998 - Present Reviewer - Southern Medical Journal1999 - Present Reviewer - American Family Physician 1999 - Present Reviewer - Journal of the American Medical Woman’s Association

62

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%5BOID%5BA6B6771AF5D09148BBFD8E7CDDE77E6E%5D%5D



2000 – Present Reviewer – Dermatologic Surgery2000 – Present Reviewer – Diabetes Care2001 – Present Reviewer - Journal of the European Academy of Dermatology and

Venereology2001 – Present Reviewer - American Journal of Clinical Dermatology2001 – Present Reviewer – International Journal of Dermatology 2001 – Present Reviewer – American Journal of Epidemiology2002 – Present Reviewer – Nature Medicine

2002 – Present Reviewer – Lancet2002 – Present Reviewer – Mayo Clinic Proceedings2003 – Present Reviewer – Pediatric Dermatology2003 – Present Reviewer – Journal of the European Academy of Dermatology2004 – Present Reviewer – Molecular Therapy2005 – Present Reviewer – Cancer2005 – Present Reviewer – Journal of Dermatologic Science2006 – Present Reviewer – Annals of Family Medicine

Journal Referring within last 3 years- Southern Medical Journal- Journal of the American Academy of Dermatology- Archives of Dermatology- American Journal of Managed Care- American Journal of Medicine- Advances in Skin and Wound Care- American Family Physician- Wounds- Ostomy/Wound Management- Diabetes Care- Dermatologic Surgery- Nature Medicine- Lancet- American Journal of Epidemiology– Mayo Clinic Proceedings- Am Journal of Clinical Dermatology- International Journal of Dermatology- Pediatric Dermatology- Journal of the European Academy of Dermatology- Molecular Therapy- Cancer- Journal of Dermatologic Science- Annals of Family Medicine- Journal of Investigative Dermatology

- Annals of Internal Medicine

63

SOCIETY MEMBERSHIPS

1984 - Present American Medical Association 1995 - Present Fellow, American Academy of Dermatology 1995- Present Florida Society of Dermatology and Dermatologic Surgery

1996 - Present International DermatoEpidemiology AssociationMedical Dermatology SocietyAssociation for the Advancement of Wound CareSociety of Investigative DermatologyLa Sociaedad Chilena De Dermatologia Y VenereologiaResidency Curriculum Exchange Group

1998 - Present Wound Healing SocietyEuropean Society for Tissue Repair

1999 - Present Miami Dermatological Society2000 – Present Argentinian Medical Association

OTHER PROFESSIONAL ACTIVITIES

07/95 - 7/96 Physician ConsultantSkin Care Attack Team (SCAT)Jackson Memorial Hospital

09/95 - Present Board of Directors - Founding memberThe Association for the Advancement of Wound Care

02/97 - Present Board MemberCME Advisory CommitteeHealth Management Publications

04/97-Present Board MemberAccreditation Advisory BoardAmerican Academy of Wound Management

09/96-09/97 Member: International CommitteeReunion Internacional de Terapeutic DermatologicaSan Salvador, El Salvador

09/96- Present Member: International CommitteeDermatology Therapy International

10/97-Present Board MemberAmerican Academy of Wound Management

64

12/97-12/00 Director: Wound Healing PreceptorshipOrtho-McNeil Pharmaceuticals

01/00- 01/03 Membership chairpersonMiami Dermatological Society

04/98- 04/00 TreasurerAssociation for the Advancement of Wound Care

04/00- 4/02 President- ElectAssociation for the Advancement of Wound Care

04/02- 4/04 PresidentAssociation for the Advancement of Wound Care

05/04- Present Immediate Past PresidentAssociation for the Advancement of Wound Care

05/03 -Present Member, Board of DirectorsFlorida Society of Dermatology and Dermatologic Surgery

06/04 -6/05 Vice- President Florida Society of Dermatology and Dermatologic Surgery

06/05 -5/06 President -ElectFlorida Society of Dermatology and Dermatologic Surgery

05/06- Present Member, Board of DirectorsWound Healing Society

06/06 – 6/07 President Florida Society of Dermatology and Dermatologic Surgery

06/07- Present Immediate Past President Florida Society of Dermatology and Dermatologic Surgery

EXAMINING BOARD MEMBERSHIPS

"Not applicable"

STUDY SECTION AND COUNCIL MEMBERSHIPS

04/94 - Present Chairperson Planning Committee Advanced Wound Care Symposium Medical Research Forum

65

07/95 - 02/97 Special Consultant Quality of Care Committee American Academy of Dermatology

07/96 – 3/01 MemberCost-Effectiveness Task ForceAmerican Academy of Dermatology

02/97- 3/04 Member Quality of Care CommitteeAmerican Academy of Dermatology

01/99- Present MemberHealth Policy CommitteeMedical Dermatology Society

02/99- 4/00 MemberMedical Dermatology Sub GroupProgram for Dermatology for the 21st CenturyAmerican Academy of Dermatology

02/99- 4/00 MemberFair Valuation Sub GroupProgram for Dermatology for the 21st CenturyAmerican Academy of Dermatology

07/99 - Present Co-Chairperson Advanced Wound Care Symposium Medical Research Forum

04/00- Present MemberGuidelines CommitteeAmerican Academy of Dermatology

05/03- Present Member and Executive Board Member Florida Cancer Control and Research Advisory Council

02/04- 8/04 Chair Quality of Care CommitteeAmerican Academy of Dermatology

08/04- 2/05 Co-chairPractice Management Task ForceAmerican Academy of Dermatology

66

011/04- Present ChairQuality Assurance/Quality Improvement Task ForceAmerican Academy of Dermatology

02/05- Present ChairPractice Management Task ForceAmerican Academy of Dermatology

10/05-Present ChairFlorida Task Force on Sun Protection for ChildrenAmerican Academy of Dermatology

04/08-03/09 Deputy ChairMaintenance of Certification CommitteeAmerican Academy of Dermatology

04/09-01/11 ChairpersonMaintenance of Certification CommitteeAmerican Academy of Dermatology

04/10- 01/11 Deputy Chair Council on Education American Academy of Dermatology

02/11-Present Chair Council on Education and Maintenance of CertificationAmerican Academy of Dermatology

CONSULTANSHIPS

"Not applicable"

HONORS AND AWARDS

07/85 NATIONAL INSTITUTES OF HEALTH Summer Fellowship

11/91 UPJOHN CORP. Young Investigator Award

06/95 George Ioannides Teaching Award

06/96 Most Valuable Player Award

67

1996 Dermatology Resident Class

1998, 1999 Best Doctors in America2002, 2005,2006, 2007,2008, 2009,2010, 2012,2013

1998 United Way of Dade CountyNominee: Monsignor Walsh Outstanding HumanServices Professional Award

1998- Present Best Doctors in South Florida

1999 Camillus House Special Award for In Kind Giving

1999 Award for Excellence in Teaching: GEST Program: Co-DirectorAmerican Academy of Dermatology

1999 Deans Award for Clinical Research Investigator: Junior FacultyUniversity of Miami School of Medicine

1999 Teaching AwardUniversity of Miami School of Medicine

2000 Who’s Who in Healthcare and Medicine

2001 Resident Teaching AwardUniversity of Miami Department of Dermatology

2002 Alpha Omega Alpha (AOA) – Faculty member

2006 American Academy of Dermatology Award for Volunteerism

2007 Founders Award, Symposium for Advanced Wound Care

2009 Induction Alpha Omega Alpha (AOA) – Alumni

2009 Induction Iron Arrow- UM Honor Society (Highest Honor at UM)

2008 UM Faculty nominee for AAMC Humanism in Medicine Award

2009 Induction Delta Omega – Public Health Honor Society

68

2011 Distinguished Service Award – Florida Society of Dermatology and Dermatologic Surgery

2013 Practitioner of the Year – Florida Society of Dermatology and

Dermatologic Surgery

Visiting professorships and Named Lectureships

Visiting Professor. University of South Florida College of Medicine, Dermatology and Cutaneous Surgery/Florida West Coast Society Meeting, August 08, 1995, Tampa, Fl.

Visiting Lecturer. Panama Canal Commission, August 19-20, 1996,Panama City, Panama.

Visiting Professor. St. Louis University School of Medicine, Department of Dermatology, November 11-12, 1998, St. Louis, MO.

Visiting Professor. Oregon Health Sciences University, Dermatology/Oregon Dermatology Meeting, February 11-12, 2003, Portland, Oregon.

Edward Miller, MD Memorial Lectureship- Florida Society of Dermatology and Dermatologic Surgery May 2008 annual meeting-

Norman Fogel, MD Memorial Lectureship- Florida Society of Dermatology and Dermatologic Surgery May 2009 annual meeting-

Frederick Malkinson, MD Lectureship- Chicago Dermatologic Surgery May 20 2009 -

Bernard Honingsberg Lectureship -University of Pennsylvania Department of Dermatology June 4, 2009

Visiting Professor. Virginia Commonwealth University, of Cincinnati Department of Dermatology/Cincinnati Dermatology Meeting, 2011, Richmond VA

Visiting Professor. University of Louisville School of Medicine, Department of Dermatology, 2012 Louisville, KY.

Visiting Professor. University, of Cincinnati Department of Dermatology/Cincinnati Dermatology Meeting, 2012, Cincinnati Ohio

Visiting Professor. University of South Florida College of Medicine, Dermatology and Cutaneous Surgery/Florida West Coast Society Meeting, 2012, Tampa, Fl.

Raul Fleischmayer Memorial Lectureship –Mt Sinai School of Medicine Department of Dermatology April 2013

69

Visiting Professor. Arthur C. Curtis & Michigan Dermatological Society. University of Michigan Department of Dermatology, April 2015

Scientific presentations at national and international meetings Available upon request

VI. CURRENT AND PAST TEACHING RESPONSIBILITIES

07/94 - 6/96 Coordinator - Dermatology Education UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

07/94 – 3/04 Director - Mechanisms of Disease Course, 04/10-Present Dermatology Section UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

Member - Curriculum Committee UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

11/95- Present Lecturer - Pharmacology CourseUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

04/95- Present Lecturer - Clinical Skills CourseUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

04/95- Present Lecturer - Mechanisms of Disease CourseUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

08/96- 08/99 Co-Coordinator- Graduate Course in Tissue Repair and Chronic WoundsUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

05/97- 05/98 Lecturer - Primary Care ClerkshipUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

05/99 – 6/01 Director - Wound Healing SchoolDepartment of Dermatology & Cutaneous SurgeryUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

THESIS AND DISSERTATION ADVISING

07/99 – 4/01 Mary Beth ReganDoctoral Candidate UM School of Nursing

70

06/06 – Present Panta RouhaniDoctoral Candidate Epidemiology

VII. SERVICE

DEPARTMENTAL ADMINISTRATIVE AND COMMITTEE RESPONSIBILITIES

07/95 - Present Co-Director - G.E.S.T. Fellowship ProgramDEPARTMENT OF DERMATOLOGY AND CUTANEOUS SURGERYUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

02/97 - 5/98 Co-Director- Wound C.U.R.E. Center

UNIVERSITY OF MIAMI/COLUMBIA-CEDARS MEDICAL CENTER

06/98 - Present Director- Wound C.U.R.E. CenterUNIVERSITY OF MIAMI/COLUMBIA-CEDARS MEDICAL CENTER

10/97 – 10/99 Member - PhD-MPH Curriculum CommitteeDEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTHUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

04/98 – 9/00 Member - Resident Research CommitteeDEPARTMENT OF DERMATOLOGY AND CUTANEOUS SURGERYUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

04/98 - Present Chair- Research Policy Task ForceDEPARTMENT OF DERMATOLOGY AND CUTANEOUS SURGERYUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

EXTRA - DEPARTMENTAL ADMINISTRATIVE AND COMMITTEE RESPONSIBILITIES

06/97 - 12/97 Member - Utilization Review CommitteeCOLUMBIA-CEDARS MEDICAL CENTER

01/98 – 12/00 Member - Credentials Committee COLUMBIA-CEDARS MEDICAL CENTER

12/98 – 12/00 Member, Institutional Review Board, Professional Misconduct Committee

71

UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

9/00 – Present Melanoma Tumor BoardUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

2/01 – 4/02 LCME Medical Education Task ForceUNIVERSITY OF MIAMI SCHOOL OF MEDICINE

COMMUNITY SERVICE

10/93 - Present Camillus House Health ConcernBi-weekly dermatology clinic

02/94 - 02/98 Florida Keys Health Fair05/94 - Present Melanoma/Skin Cancer Screening Program09/96 National Psoriasis Foundation Lecturer11/96 Miami Transplant Society Lecturer12/01 - Present Advisor – Skin Care Curriculum –Miami-Dade County School

Board*****

72

university of miami - ohio state university · web viewobstetrics & gynecology 2005;105:1381-8....

Documents